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Abstract 
During anaphase, chromosomes move toward the spindle poles by 
forces transmitted through their kinetochore fibres. The fibres 
contain microtubules, as well as actin and myosin, which work 
together to produce the force that moves chromosomes. If 
tropomyosin functions in the spindle, as it does in other actin 
microfilament systems, then it may regulate actin filaments 
along kinetochore fibres. The purpose of my thesis was to 
investigate whether tropomyosin has possible roles during 
anaphase chromosome movement. 
Anaphase cells were treated with different inhibitory drugs 
against tropomyosin. Chromosome movement was altered by an 
upstream kinase inhibitor and was sometimes altered by a direct 
binding inhibitor. This may be due to possible time constraints. 
Furthermore, tropomyosin localized to the spindle poles and 
kinetochore fibres of the meiotic spindle of crane-fly primary 
spermatocytes. Overall, the data support the idea that 
tropomyosin is present in the spindle, where it may function 
during anaphase chromosome movement.  
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General Introduction 
A. The Spindle 
The spindle apparatus assembles during cell division and is 
responsible for separating chromosomes into two daughter nuclei 
(Schrader 1953). In animal cells, it is fusiform in shape, with 
spindle poles on opposite ends, and composed of birefringent 
material (Inoue 1953, Forer and Zimmerman 1976, Inoue 1988). 
Three types of birefringent fibres can be observed in the 
spindle including continuous fibres, that extend between spindle 
poles, interzonal fibres, that extend between separating 
chromosomes during anaphase or telophase, and chromosomal 
fibres, that extend between the kinetochores of the chromosomes 
and the spindle poles (Inoue 1953). The kinetochore is the site 
on the chromosome to which the chromosomal or kinetochore fibre 
attaches. The fibres can attach to kinetochores in one of 
several ways (Compton et al. 2007) although, for the purposes of 
my thesis, I will on focus amphitelic or bioriented attachment 
(Figure 1). The kinetochore fibres are responsible for 
transmitting force to the chromosomes which causes them to move 
(Forer 1980).  
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Figure 1 – Different types of kinetochore fibre attachment 
observed in the spindle. Kinetochore fibres from one spindle 
pole can attach to one (monotely) or both (syntely) of the 
sister kinetochores. Kinetochore fibres from opposite spindle 
poles can attach to sister kinetochores equally (amphitely) or 
unequally (merotely). Image modified from Compton et al. (2007). 
Originally published in Journal of Cell Biology. 
DOI: 10.1083/jcb.200709152. 
 
 Cell division can occur through mitosis or meiosis. Mitosis 
occurs in somatic tissue while meiosis occurs exclusively in 
germ line cells. In mitosis, replicated chromosomes are 
separated through an equational division producing two identical 
diploid daughter cells. Meiosis, on the other hand, generally 
occurs through two rounds of division, meiosis-I and meiosis-II, 
and produces four unique daughter cells with haploid numbers of 
chromosomes. The meiotic divisions include one reductional and 
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one equational division (Ris 1949). The reductional division, 
generally first, divides the number of chromosomes in half, 
producing haploid daughter cells. Mitosis and meiosis progress 
through similar stages, with some critical exceptions. The 
stages of mitosis generally include prophase, prometaphase, 
metaphase, anaphase, telophase and cytokinesis. The stages of 
meiosis-I and -II include prophases-I and -II through 
telophases-I and -II, respectively. The stages of mitosis as 
well as the unique events of meiosis will be discussed in the 
following sections.   
B. The Mitosis Spindle:  
B.1 Prophase 
During prophase, chromosomes condense and duplicated 
centrosomes, which are the microtubule organizing centers 
(MTOC), move apart. Replicated chromosomes are composed of 
sister chromatids that are attached at the centromere and appear 
as paired chromatids by late prophase (Sumner 1991).  
B.2 Prometaphase 
Prometaphase begins with nuclear membrane breakdown which allows 
kinetochore fibres to capture chromosomes at their kinetochores 
and move them toward the equator. Chromosomes congress toward 
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the equator and, moving past and back, either prior to or after 
becoming bioriented (Kapoor et al. 2006).  
B.3 Metaphase  
Chromosomes become aligned at the equator at metaphase and 
bioriented sister kinetochores attach to opposite spindle poles 
through their kinetochore fibres (reviewed in Scholey et al. 
2003). 
B.4 Anaphase 
During anaphase, the cohesin complex which holds paired sister 
chromatids together disassembles (Nasymth 2002) and the 
chromatids move toward opposite spindle poles. Anaphase includes 
two distinct phases; during the first phase, kinetochore fibres 
shorten as kinetochores move toward spindle poles and, during 
the second phase, the spindle elongates as the spindle poles 
move apart (Hughes and Swann 1948, Ris 1943, Ris 1949, Taylor 
1965). These phases, referred to as anaphases A and B, can occur 
simultaneously, concurrently in either order or exclusively.   
B.5 Telophase 
By telophase, the two sets of daughter chromosomes arrive at 
opposite spindle poles and decondense. New nuclear membranes 
assemble around each set of chromosomes creating two daughter 
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nuclei and marking the end of mitosis (reviewed in Scholey et 
al. 2003). The division of cytoplasm begins after the 
contractile ring forms and constricts.  
B.6 Cytokinesis 
During cytokinesis, the contractile ring forms a cleavage furrow 
which ingresses, creating two daughter cells. The contractile 
ring is composed primarily of actin and myosin (Schroeder 1973, 
Fujiwara and Pollard 1976, Fujiwara et al. 1978, Vavylonis et 
al. 2008).    
C. The Meiotic Spindle  
Meiosis is responsible for producing genetically unique haploid 
sex cells through a process called gametogenesis. Briefly, 
primary gametocytes undergo meiosis-I division and produce 
secondary gametocytes, which in turn undergo meiosis-II division 
and produce gametids. These later develop into haploid gametes. 
The stages of meiosis resemble mitosis with some critical 
exceptions, which will be discussed here.   
 Meiosis-I is typically a reductional division that results 
in haploid daughter cells (Ris 1949). During prophase-I, non-
sister chromatids from pairs of replicated homologous 
chromosomes undergo crossing over at regions called chiasmata 
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(Henderson 1970). This crossing over allows genetic 
recombination to occur and the exchange of genetic material. The 
terms bivalent or tetrad refer to the pairs of homologous 
chromosomes at this stage. During the metaphase-I to anaphase-I 
transition, and throughout anaphase, the cohesin complex holding 
sister chromatids together does not disassemble and sister 
kinetochores are pulled toward the same spindle pole (Watanabe 
2004). Unlike mitosis, replicated chromosomes therefore remain 
together, while homologous pairs separate. As a result, the 
daughter nuclei contain half of the chromosome complement of the 
parent cell. Meiosis-II follows meiosis-I and is an equational 
division, similar to mitosis. In some females, such as mammals 
and birds, meiosis arrests at different divisional stages such 
as prophase-I and, as a result, meiotic events do not occur 
sequentially (Mira 1998). In addition, in some organisms such as 
the coccids, meiosis-I is equational while meiosis-II is 
reductional (Brown and Nelson-Rees 1961).   
D. The Spindle: Microtubules as force producers 
Microtubules are ubiquitous cytoskeletal filaments involved in 
various types of cellular movement. They are composed of αβ-
tubulin heterodimers and form hollow tubes (Downing and Nogales 
1998). When microtubules assemble, the plus end typically 
incorporates subunits faster than the minus end and assembly is 
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accompanied by GTP hydrolysis by β-tubulin. In the cell, 
microtubules preferentially nucleate in a region called the 
microtubule organizing center or centrosome (Wade 2009). During 
cell division in animal cells, the centrosome duplicates and one 
centrosome locates to each spindle pole. An important feature of 
microtubules is that they display dynamic instability and 
fluctuate between growth and shrinkage (Wade and Hyman 1997). 
They are also capable of treadmilling, as tubulin subunits can 
be incorporated and lost on opposite ends of the microtubule 
filament without length change (Grego et al. 2001, Figure 2).  
 
Figure 2 – Microtubule dynamics showing dynamic instability and 
treadmilling. A) tubulin subunits can be incorporated or lost 
from either end of the microtubule filament. B) tubulin subunits 
are added and lost on opposite ends of the microtubule filament.  
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Microtubules compose the majority of the spindle structure 
and evidence suggesting they are involved in spindle function 
comes from studies demonstrating the dynamic behaviour of 
kinetochore fibre microtubules (Mitchison 1988). These 
microtubules are part of the kinetochore fibres extending 
between the spindle pole and the kinetochores of the 
chromosomes. The plus ends of the microtubules are located at 
the kinetochores while the minus ends are located at the spindle 
poles. Unlike non-kinetochore microtubules, these display unique 
stability against agents such as cooling, hydrostatic pressure 
and colchicine (Cassimeris et al. 1988). Two models describing 
microtubules as the force producers for chromosome movement 
include the Flux and Pac-Man models which will be discussed in 
the following section.  
D.1 The Flux model 
The Flux model is based on poleward movement of microtubules 
because of minus end disassembly at the spindle pole (Maddox et 
al. 2003). In this model, microtubule polymerization takes place 
at the kinetochore and depolymerization takes place at the 
spindle pole (MTOC). Briefly, tubulin is incorporated at the 
kinetochore and moves along the kinetochore fibre toward the 
spindle pole where it is lost. During metaphase, equal rates of 
polymerization and depolymerization maintain the length of the 
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kinetochore fibre (Mitchison 1989). However, during anaphase A, 
depolymerization occurs at a faster rate than polymerization, 
which results in kinetochore fibre shortening as chromosomes 
move poleward. Tubulin flux continues throughout anaphase A 
while kinetochore fibres shorten (Wadsworth et al. 1989, 
LaFountain et al. 2004). In crane-fly primary spermatocytes 
(LaFountain et al. 2004), tubulin subunits continue to 
incorporate at the kinetochore showing that depolymerization 
occurs primarily, if not exclusively, at the pole. 
 Different proteins have been implicated in the Flux model 
(reviewed in Rogers et al. 2005, Figure 3). A series of 
experiments conducted in Drosophila showed that a Kin-1 kinesin, 
KLP10A, functioned by depolymerizing microtubules at the mitotic 
spindle pole as well as facilitating poleward flux during 
anaphase (Rogers et al. 2004). In another set of experiments 
conducted in Drosophila, it was shown that the CLASP orthologue, 
MAST/Orbit, localizes to kinetochores where it is essential for 
incorporating tubulin during flux (Maiato et al. 2005). Lastly, 
it has been suggested that a kinesin-5 protein, Eg5, drives flux 
by promoting microtubule sliding (Miyamoto et al. 2004). The 
Flux model proposes that kinesin-driven depolymerization at the 
spindle pole generates the force required for microtubule flux 
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and, furthermore, that flux exerts a pulling force moving 
chromosomes toward spindle poles (Rogers et al. 2005).   
 
Figure 3 – Proteins involved in the Flux model for chromosome 
movement. Kin-1 kinesin localizes to the spindle pole where it 
acts to depolymerize kinetochore fibre microtubules. CLASP1 
localizes to the kinetochore where it promotes mictrotubule 
polymerization. Mictrotubules flux toward the spindle pole 
during metaphase, as kinetochore fibres maintain their length, 
and anaphase, as kinetochore fibres shorten and chromosomes move 
poleward.  
 
D. 2 The Pac-Man model 
The Pac-Man model is based on evidence suggesting that poleward 
force is generated at the kinetochore, as opposed to being along 
the kinetochore fibre or at the spindle pole (Cassimeris et al. 
1987). Contrary to the Flux model, the Pac-Man model proposes 
that microtubules depolymerize at the kinetochore as chromosomes 
chew their way poleward along kinetochore fibres. For example, 
chromosomes have been shown to move poleward during anaphase 
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while photobleached regions along the kinetochore fibres remain 
stationary with respect to the spindle pole to which they are 
attached (Gorbsky et al. 1987). These results suggest that 
kinetochore fibre shortening is due to depolymerization at the 
kinetochore, as opposed to the spindle pole. In addition, 
photobleached regions along kinetochore fibres do not move 
poleward during metaphase and tubulin flux does not account for 
fluorescence recovery (Wadsworth and Salmon 1986). Together, 
these data suggest that kinetochore fibre microtubules are 
stationary and that kinetochore fibre shortening is due to 
depolymerization at the kinetochore. It has also been suggested 
that the motor driving poleward chromosome movement is at or 
near the kinetochore (Nicklas 1989). Briefly, chromosomes 
continued moving poleward after their kinetochore fibres were 
cut in a region lying between the chromosome and the spindle 
pole. This suggests that poleward chromosome movement is driven 
by a force generated at or near the kinetochore, as opposed to 
being generated at the spindle pole.    
Recent data suggests that the Pac-Man and Flux models may 
work concurrently to produce poleward chromosome movement during 
anaphase A and that microtubule severing proteins are involved 
(Zhang et al. 2007). In a series of experiments conducted in 
Drosophila, three microtubule severing proteins, including 
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Katanin, Spastin and Fidgetin, were shown to affect both 
microtubule flux and microtubule depolymerization at the 
kinetochore. Briefly, Katanin was proposed to sever microtubules 
at the kinetochore allowing them to be depolymerized in 
accordance with the Pac-Man model. Spastin and Fidgetin, on the 
other hand, were proposed to sever microtubules at the 
centrosomes allowing the microtubules to be depolymerized in 
accordance with the Flux model. These data demonstrate how the 
Flux and Pac-Man models can work together to produce a viable 
mechanism for chromosome movement during anaphase. Whether they 
occur independently or together, both the Flux and Pac-Man 
models propose that microtubules and their associated motor 
proteins are the force producers for chromosome movement during 
anaphase.  
D.3 Confounding evidence regarding microtubules as force 
producers   
Kinetochore microtubules may not be solely responsible for 
producing the force that moves chromosomes during anaphase. 
Pickett-Heaps and Forer (2001) discuss several potential issues 
with the Pac-Man model which will be discussed here briefly. 
Firstly, in diatoms, kinetochore microtubules end at an 
“amorphous ‘collar’”, as opposed to inserting at the 
kinetochore, which would be required for the Pac-Man model to 
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work. Secondly, when whole chromosomes were removed from cells 
using micromanipulation, the spindles remained and kinetochore 
fibres still shortened. This suggests that fibre shortening 
occurs through forces other than those at the kinetochore (Zhang 
and Nicklas 1996). Thirdly, when single kinetochore fibres were 
cut with UV microbeam, chromosomes and their associated 
kinetochore stubs continued moving poleward and sometimes 
accelerated. This suggests that suggests that microtubules may 
actually limit the rate at which chromosomes move toward their 
respective spindle poles. In sum, these data demonstrate that 
the Pac-Man model, which identifies kinetochore microtubules as 
the producers of force (Cassimeris et al. 1987), does not 
account for all chromosome movement during anaphase A. In the 
flux model, kinetochore microtubules exhibit polymerization and 
depolymerization at the kinetochore and pole, respectively, 
fluxing tubulin poleward (Wilson et al. 1994, LaFountain et al. 
2004). The model proposes that tubulin flux is responsible for 
producing the force that moves chromosomes poleward (Rogers et 
al. 2005). However, although microtubule flux occurs along 
kinetochore fibres during anaphase A, this does not implicate 
microtubules as the producers of force per se. For example, 
tubulin flux may be driven by an actomyosin mechanism acting on 
kinetochore fibre microtubules as opposed to being intrinsically 
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driven or driven by microtubule motor proteins (Silverman-
Gavrila and Forer 2000, Forer et al. 2007). 
 In consideration of the potential problems with the Flux 
and Pac-Man models, which focus on microtubule-based mechanisms 
for force production, it is important to consider other likely 
force producers for chromosome movement. Specifically, actin 
microfilaments and associated myosin motor proteins.   
E. The spindle: Actin and Myosin as force producers 
Actin and myosin are parts of the spindle and have been 
implicated as force producers for chromosome movement. Forer et 
al. (2003) provide a comprehensive review of the reports of 
actin and myosin in various mitotic and meiotic spindles as well 
as the effects of anti-actin and anti-myosin drugs on spindle 
function. Briefly, by 2003, actin had been localized in spindles 
of twenty-three different organisms through various techniques 
including fluorescence microscopy of fixed cells, electron 
microscopy and labelling with heavy meromyosin and fluorescence 
microscopy of living cells with fluorescently labelled actin or 
phalloidin. In particular, actin was shown to associate with 
kinetochore fibres. Myosin had been localized in the spindles of 
seven different organisms via fluorescence microscopy of fixed 
cells and fluorescently labelled myosin in living cells. 
Together, these data indicate that actin and myosin are parts of 
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the spindle apparatus and that they localize to kinetochore 
fibres along with microtubules. With respect to actin and myosin 
function in the spindle, different anti-actin and anti-myosin 
drugs were shown to perturb several spindle functions. Of 
particular interest, inhibitory drugs against either actin or 
myosin altered anaphase chromosome movement as well they blocked 
tubulin flux along kinetochore fibre microtubules. These results 
are important because they implicate actin and myosin as force 
producers for chromosome movement.  
 In crane-fly primary spermatocytes, actin and myosin 
contribute to producing the force that moves chromosomes during 
anaphase. The anti-actin drugs cytochalasin D (CD) and 
latrunculin (LAT) slow or stop chromosome movement when applied 
during anaphase (Forer and Pickett-Heaps 1998). These results 
suggest that actin is involved in poleward chromosome movement. 
Similar results were observed with the anti-myosin drug 2,3-
butanedione 2-monoxime (BDM) (Silverman-Gavrila and Forer 2001). 
When applied during anaphase, chromosomes slowed, stopped or 
moved backward and generally resumed movement when BDM was 
washed out. Additionally, when the myosin inhibitory drugs ML-7 
and Y27632 were applied during anaphase, chromosome movement 
slowed or stopped (Sheykhani et al. 2013). Sheykhani et al. 
(2013) also showed that the kinetochore fibres corresponding to 
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chromosomes that displayed altered movement showed reduced 
levels of myosin phosphorylation. This suggests that myosin is 
involved in anaphase chromosome movement and, in particular, 
myosin phosphorylation is involved in force production. 
Conversely, when the myosin enhancer calyculin A (CalA) was 
added during anaphase, poleward movement accelerated for all 
bivalent pairs within the same cell (Fabian et al. 2007). 
Lastly, when the actin stabilizing drug jasplakinlide was added 
during anaphase, chromosome movement was also altered (Xie and 
Forer 2008). Autosomal bivalents stopped, slowed, had no effect, 
or very rarely accelerated. Occasionally, movement recovered 
after stopping while still in jasplakinolide. In general, the 
autosomal bivalent pairs between cells and within a single cell 
did not react the same to any of these drugs, with the exception 
of CalA. This suggests that several force systems are operating 
in the spindle and that different combinations of these force 
generators can be used within the same cell. In order to better 
elucidate the mechanism of force production in the spindle, it 
is worthwhile investigating whether other proteins that are 
known to function with actin and myosin are involved.      
F. Complementary systems 
Actin and myosin are ubiquitous proteins present in several 
other cytoskeletal systems. Understanding how these proteins are 
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structured and function in other systems, referred to here as 
complementary systems, may help to understand how they may be 
structured and function in the spindle. 
F.1 Complementary systems: Actin and myosin in muscle cells 
Muscles are force generating tissues that display unique 
structural and functional properties. Each type of muscle 
including cardiac, smooth and skeletal or striated muscle, all 
function using actin and myosin but through somewhat different 
mechanisms. For the purposes of my thesis, I describe the 
actomyosin mechanism of force production in striated muscle. The 
following section will describe the composition, organization 
and contractile mechanism of striated muscle. Later, I expound 
upon how tropomyosin, a regulatory muscle protein, may function 
in other motile systems involving actomyosin based force 
production.  
Striated muscle shows a characteristic banding pattern 
observed under phase contrast light microscopy and/or electron 
microscopy. This banding pattern is also observed in cardiac 
muscle (Moore and Ruska 1957) although it has slight structural 
and compositional differences. The banding pattern results from 
alternating bands of birefringence and non-birefringence, known 
as the A (anisotropic) and I (isotropic) bands respectively 
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(Huxley and Hanson 1957). Electron microscopy analysis reveals 
that the I bands contain only thin filaments while the A bands 
contain a compound array of both thin and thick filaments 
(Huxley 1953). An H zone is embedded in the center of every A 
band which contains a simple array of only thick filaments. It 
is bisected by an M line or midline which represents the center 
of the repeating unit of the banding pattern. The repeating 
units, flanked by Z lines, are referred to as sarcomeres and are 
the functional units of striated muscle (Figure 4).  
 
Figure 4 – Schematic of the sarcomere repeat in striated muscle. 
The I band contains thin filaments, the A band contains thin and 
thick filaments and the H zone contains only thick filaments. 
Thin and thick filaments overlap in the A band. The M line 
(midline) bissects the thick filaments in the center of the H 
zone. Image modified from Squire (1997). Originally published in 
Current Opinion in Structural Biology. DOI: 10.1016/S0959-
440X(97)80033-4.  
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Muscle cells are able to convert stored chemical energy 
into useful mechanical work which causes muscular contractions. 
The sliding filament model is based on the structural 
arrangement of the sarcomere and describes how the thin and 
thick filaments work together to produce contractile force 
(reviewed in Huxley 1969). Briefly, actin-containing thin 
filaments interact with thick filaments, that are composed of 
myosin molecules, within the A band where they overlap. This 
interaction is facilitated by cross-bridges that extend between 
the filaments and represent the S-1 globular regions of the 
heavy meromyosin (HMM) heads of myosin molecules. They contain 
an actin binding site as well as ATPase and ATP receptor sites. 
The cross-bridges display opposite orientations in either half-
sarcomere because they reverse orientation along the thick 
filaments at the M line (Huxley 1963). The cross-bridge 
orientation directs force production toward the center of the 
sarcomere, causing the sarcomere to shorten during contraction. 
A common method for determining the structural polarity of 
actin-containing filaments is to “decorate” the filaments with 
HMM or the S-1 fragments of HMM (Moore et al. 1970, Forer 1974, 
Forer 1982a). Briefly, HMM or HMM-S-1 will bind to polar actin 
filaments and form uniformly oriented arrowhead complexes along 
the lengths of the filaments (Figure 5).  
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Figure 5 – “Decorated” actin  filaments treated with HMM showing 
arrowhead complexes oriented with definite structural polarity. 
(a) sectioned myotube treated with HMM. (b) enlarged image of a 
polar actin filament showing HMM arrowhead complexes. (c) 
schematic of a polar actin filament with arrowheads all pointed 
in the direction of force production. Images (a) and (b) 
modified from Ishikawa et al. (1969). Originally published in 
The Journal of Cell Biology.  
 
The arrowheads point in the direction in which the 
filaments generate force by interacting with myosin (Begg et al. 
1978). Therefore, arrowheads can give clues to help understand 
the functional mechanism through which actomyosin interactions 
generate force. In striated muscle, the arrowhead complexes 
point toward the M line (Woodrum et al. 1975). Determining the 
polarity of actin-containing filaments can be useful when trying 
to understand their functional mechanism. Furthermore, 
actomyosin based motile systems that display similar filament 
polarity to striated muscle may also share similar functional 
mechanisms.  
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Actomyosin based force production in striated muscle is 
generated by cross-bridge cycling (reviewed in Fitts 2008). 
Briefly, the cycle begins when myosin ATPase hydrolyses ATP and 
the HMM heads bind to the actin filaments with weak affinity. 
The HMM heads then become strongly bound, causing the actomyosin 
complex to enter a “high force” state. In this state, the HMM 
heads release inorganic phosphate, which is associated with the 
power stroke (Kraft et al. 2005). During the power stroke, the 
myosin molecules pivot at the junction between the HMM and LMM 
chains (Tyska and Warshaw 2002) causing the thin filaments to 
slide past the thick filaments toward the center of the 
sarcomere. The HMM heads then release ADP, bind to a new 
molecule of ATP and dissociate from the actin filaments, 
allowing the cycle to repeat.  
The force generating actomyosin interactions are governed 
by cofactors and other regulatory proteins. In the absence of 
calcium ions (Ca2+) actomyosin interactions are inhibited by 
troponin and tropomyosin which are part of the thin filaments 
(reviewed in Wakabayashi et al. 1975, Figure 6). During a 
contraction, electrical impulses trigger Ca2+ to be released from 
the sarcoplasmic reticulum into the cytoplasm. The Ca2+ binds to 
troponin C which induces a conformational change and shift in 
tropomyosin.  
22 
 
 
Figure 6 – Schematic representation of the protein arrangement 
in the thin filaments of striated muscle. The troponin molecule 
is composed of troponin-C, which binds Ca2+, troponin-T, which 
binds tropomyosin, and troponin-I, which the inhibitory 
component of troponin (Hitchcock 1975). Tropomyosin lies in the 
major groove of the actin filament. Image from Lees-Miller and 
Helfman (1991). Originally published in Bioessays. DOI: 
10.1002/bies.950130902. 
 
This shift is exposes the myosin binding sites on actin, 
allowing myosin to bind actin with strong affinity. The 
actomyosin complex now enters the “high force” state, myosin 
releases Pi and the power stroke occurs. Troponin and tropomyosin 
therefore act as regulators of actomyosin interactions in 
striated muscle. Troponin is necessary to induce a 
conformational change in tropomyosin (Wakabayashi et al. 1975) 
and tropomyosin mediates actin-myosin binding affinity. By 
controlling actomyosin interactions, troponin and tropomyosin 
regulate force production and are necessary to produce 
purposeful contractile force. For example, purified actomyosin 
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is insensitive to Ca2+, remaining in the active state whether Ca2+ 
is present or absent (reviewed in Huxley 1969). With respect to 
the exact mechanism through which tropomyosin works, recent data 
suggests that it may act as an allosteric switch as opposed to a 
steric blocker (reviewed in Gunning et al. 2008). In the latter, 
strong actomyosin interactions are sterically blocked by 
tropomyosin, until it shifts and permits myosin to bind actin 
with strong affinity (Bacchiocchi and Lehrer 2002). However, 
whether the tropomyosin shift actually causes myosin to bind 
actin with strong affinity has yet to be established and, 
furthermore, there is no evidence that tropomyosin alone is able 
to inhibit actomyosin interactions (Patchell et al. 2002, 
Patchell et al. 2005). It appears that troponin-I alters 
actomyosin binding through its interaction with myosin, while 
tropomyosin enhances this interaction while also regulating the 
conformation of actin monomers in the filament (see Gunning et 
al. 2005). Therefore, it appears that the role of tropomyosin in 
striated muscle may be more related to the actin filaments as 
opposed to myosin binding.     
Actomyosin based mechanisms are also responsible for 
generating contractile force in smooth muscles, although smooth 
muscle is not arranged in sarcomeres (Huxley 1958) and troponin 
is not involved. Rather, actomyosin interactions are regulated 
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by calmodulin and caldesmon (Graceffa 1987). These proteins are 
parts of the thin filaments, along with actin and tropomyosin, 
and are regulated by Ca2+. Briefly, calmodulin binds to Ca2+, 
which causes myosin light chain kinase (MLCK) to phosphorylate 
and activate the myosin light chain (MLC) subunits embedded in 
the thick filaments (reviewed in Kamm and Stull 1985). Caldesmon 
mediates actomyosin binding affinity by inhibiting phosphate 
release from HMM heads (Alahyan et al. 2006). Caldesmon 
therefore controls the affinity with which actin and myosin 
bind, permitting or inhibiting muscular contractions. Although 
the data is not yet solid, tropomyosin is thought to propagate 
the signal from caldesmon to the actin filaments.  
The structural and functional mechanisms of force 
production in striated and smooth muscle demonstrate that 
actomyosin interactions responsible for producing contractile 
force are mediated by tropomyosin and other regulatory proteins. 
If actomyosin interactions are responsible for producing force 
in other motile systems, then tropomyosin may also be involved 
(Huxley 1973). With respect to the spindle, actin and myosin are 
involved with force production for chromosome movement (reviewed 
in Forer et al. 2003, Sheykhani et al. 2013). Furthermore, 
recent data has shown that another muscle protein, titin, which 
is responsible for elasticity, colocalizes with microtubules 
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along kinetochore fibres during metaphase and anaphase in crane-
fly and locust spermatocytes (Fabian et al. 2007). It is 
therefore worthwhile investigating whether tropomyosin also 
plays a role in this system, which is what I did in my thesis 
research. If tropomyosin functions in the spindle as it does in 
muscle, then it may serve as a mediator of actomyosin 
interactions, thereby affecting force production. However, 
tropomyosin may also function in ways other than mediating 
actomyosin force production (Lazarides 1976). These will be 
discussed in the next section.   
F.2 Complementary systems: Tropomyosin in non-muscle cells 
Since its discovery in muscle (Bailey 1946) tropomyosin has been 
characterized in various non-muscle cells, demonstrating a 
diverse array of structural and functional properties. 
Tropomyosins make up a large family of alpha-helical rod-like 
dimers whose isoform diversity is generated from multiple genes 
as well as alternative RNA processing. Vertebrate tropomyosins 
are encoded by four genes that produce over 40 different 
isoforms (reviewed in Gunning et al. 2005, Schevzov et al. 
2011). This tropomyosin gene family is thought to have arisen 
through duplication of an ancestral gene (Lees-Miller and 
Helfman 1991). Currently, these genes include TMP1 (α-Tm), TPM2 
(β-Tm), TPM3 (γ-Tm) and TPM4 (δ-Tm) (Figure 7). Isoform 
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diversity is generated from sequence divergence amongst 
alternative exons within the same gene and the same exons in 
different genes (Schevzov et al. 2011). In general, tropomyosin 
isoforms can be categorized into one of two groups, namely high 
molecular weight (HMW) and low molecular weight (LMW) 
tropomyosins. HMW tropomyosins are made up of 281-284 amino acid 
residues and contain the 1a and either the 2a or 2b exons, while 
LMW tropomyosins are made up of 245-251 amino acid residues and 
contain the 1b exon (Schevzov et al. 2011). Typically, muscle 
tropomyosins, including α and β tropomyosins, belong to the HMW 
group and are encoded by TPM1 and TPM2 respectively. Non-muscle 
tropomyosins show greater isoform diversity (Pittenger et al. 
1994).  
 
Figure 7 – Intron-exon organization of the mammalian tropomyosin 
genes. TPM1 (α) and TPM2 (β) correspond to the muscle 
tropomyosins α and β, and TPM3 (also known as γ-Tm) and TPM4 
(also known as δ-Tm) correspond to non-muscle tropomyosins. HMW 
tropomyosins include the 1a and either the 2a or 2b exons, while 
LMW tropomyosins include the 1b exon. Image modified from Perry 
(2001). Originally published in Journal of Muscle Research and 
Cell Motility. DOI: 10.1023/A:1010303732441.  
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Tropomyosin isoforms display unique functional properties 
and their expression is both spatially and temporally regulated. 
Firstly, tropomyosin isoforms are tissue specific (reviewed in 
Gunning et al. 2005). For example, various mouse-derived tissues 
show differential isoform expression profiles observed via 
isoform-specific antibodies (Schevzov et al. 2005). Secondly, 
tropomyosin isoforms are expressed during specific developmental 
periods (reviewed in Gunning et al. 2008). For example, the 
digestive tissues of chicken display either different isoform 
specificity or quantitatively different isoform compositions 
between embryonic and adult tissues (Xie et al. 1991). These 
data suggest that tropomyosin isoforms perform specific 
functions and that their expression is highly regulated. Other 
organisms such as yeast and Drosophila contain fewer tropomyosin 
encoding genes. Yeast contains two tropomyosin genes, namely 
TPM1 and TPM2, whose gene products are structurally and 
functionally distinct (Drees et al. 1995). Drosophila also 
contains two tropomyosin genes that encode all of the muscle and 
non-muscle tropomyosin isoforms (Karlik and Fyrberg 1986).  
 In the cytoskeletons of non-muscle cells, tropomyosins 
serve various functions associated with the actin filaments to 
which they are bound. Tropomyosin molecules lie head-to-tail 
along the major groove of polar actin filaments with each 
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molecule spanning approximately 6-7 actin monomers (Gunning et 
al. 2005). Many of the functions conferred by tropomyosin are 
attributed to the nature of this binding. Specifically, 
tropomyosin-bound actin filaments display altered stability, 
polymerization and actin-binding protein interactions.  
Tropomyosin provides stability to actin filaments and 
alters actin filament polymerization and branching (reviewed in 
Cooper 2002). LMW non-muscle tropomyosin isoforms, for example, 
slow depolymerization at the pointed ends of actin filaments, 
possibly through the binding interaction between tropomyosin and 
actin (Broschat et al. 1989). In yeast, genetic experiments have 
indicated that tropomyosin provides actin filament stability 
(Liu and Bretscher 1989). Briefly, cytoplasmic actin cables 
containing tropomyosin were more prominent in TPM1 
overexpression mutants while they disappeared in TPM1 disruption 
mutants. On the other hand, actin structures that did not 
contain tropomyosin were unaffected. Furthermore, temperature 
sensitive mutants in which tropomyosin function was diminished 
and then enhanced showed a corresponding disappearance and 
reappearance of the actin cables. These results are consistent 
with the idea that tropomyosin confers actin filament stability. 
Tropomyosin also affects actin filament branching by the Arp2/3 
complex (Blanchoin et al. 2001). Briefly, the LMW cytoskeletal 
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tropomyosin, Tm5a, reduced the frequency of actin filament 
branching by the Arp2/3 complex, although it did not completely 
inhibit branching. In addition, the LMW tropomyosin inhibited 
branching more frequently than either of two HMW tropomyosins, 
suggesting that branch inhibition by tropomyosin is isoform 
specific. Although the mechanism was not determined, tropomyosin 
was thought to inhibit branching by binding actin filaments and 
potentially blocking Arp2/3 binding. Tropomyosin also alters 
barbed-end dynamics of actin filaments (Wawro et al. 2007). 
Different formin proteins were shown to inhibit barbed-end 
elongation of actin filaments. However, three tropomyosin 
isoforms, including Tm5a, were able to relieve this inhibition 
in an isoform-specific manner. These results suggest that 
tropomyosins and formin proteins function antagonistically at 
the barbed-ends of actin filaments. As well, they demonstrate 
the isoform specificity of different tropomyosins and their 
functions. Lastly, tropomyosins can promote stress fibre 
formation by recruiting myosin II into stress fibres (Bryce et 
al. 2003). Specifically, incorporation of the LMW cytoskeletal 
tropomyosin Tm5NM1 recruited myosin heavy chain IIA and 
phosphorylated myosin light chain into the stress fibres, which 
supports active contractility of these stress fibres. Overall, 
tropomyosins play several roles in the cytoskeletons of non-
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muscle cells. These roles predominately involve altering actin 
filament stability and dynamics which have implications for 
microfilament functioning. Tropomyosin may play similar roles in 
the spindle and alter spindle actin dynamics relating to 
stability, polymerization or actin-binding protein interactions.        
G. Tropomyosin inhibition  
Tropomyosin can be inhibited by upstream kinase inhibition or by 
direct binding inhibition. In general, successful tropomyosin 
inhibition results in the loss of actin filament integrity in 
cytoskeletal systems. Two anti-tropomyosin drugs, PD 098059 (PD) 
(Houle et al. 2003, Houle et al. 2007) and TR100 (Stehn et al. 
2013), act through entirely different mechanisms but they both 
ultimately (after several hours) result in degraded F-actin 
organization. These drugs will be discussed in the following 
section.  
G.1 Upstream kinase inhibition of tropomyosin   
PD is a synthetic, non-competitive inhibitor that specifically 
inhibits the activation and phosphorylation of inactive MAPKK 
(Alessi et al. 1995, Figure 8). A series of experiments (Alessi 
et al. 1995) showed that PD inhibits the inactive form of MAPKK 
and, furthermore, it prevents MAPKK activation and 
phosphorylation by the MAPKK kinases, c-Raf or MEK kinase. PD 
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was also tested against several other protein kinases including 
MLCK and the results suggest that this drug does not 
significantly lower their activity. The activity of these 
serine/threonine kinases following treatment with PD ranged from 
87±5 - 109±7 % of control activity, with MLCK functioning at 
88±2 % activity (Alessi et al. 1995). For comparison, MAPKK 
activity following PD treatment was lower than 20% of control 
activity. Taken together these data suggest that PD is specific 
for MAPKK and that kinases in other phosphorylation pathways are 
less affected or even unaffected.    
 
Figure 8 – Structure of PD 098059 (PD) (2’-amino-3’-
methoxyflavone). PD inhibits inactive MAPKK which prevents 
downstream phosphorylation of tropomyosin. Image from Alessi et 
al. (1995). Originally published in Journal Biological 
Chemistry. DOI: 10.1074/jbc.270.46.27489.  
  
Investigations into the effects of PD on actin filament 
organization have shown that PD disrupts proper F-actin 
formation by inhibiting MAPKK, which has the downstream effect 
of preventing tropomyosin phosphorylation (Houle et al. 2003, 
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Houle et al. 2007). Tropomyosin is not phosphorylated by either 
Phosphorylase kinase or Protein kinase A (reviewed in Perry 
2001). However, tropomyosin 1 is phosphorylated by DAP kinase-I 
(Houle et al. 2007) downstream of ERK (MAPK) (Houle et al. 2003, 
Figure 9). Briefly, H2O2 promotes F-actin assembly into stress 
fibres in non-muscle cells. PD treatment inhibits H2O2 induced 
stress fibre formation and promotes membrane blebbing and focal 
adhesion missassembly which are associated with actin filaments. 
Tropomyosin 1, a HMW cytoskeletal TPM2 gene product (Schevzov et 
al. 2011) was shown to be phosphorylated after exposure to H2O2 
but not in the presence of PD. These results demonstrate that 
tropomyosin 1 phosphorylation is necessary for F-actin to 
assemble into stress fibres and to display proper function. 
However, PD inhibits tropomyosin 1 phosphorylation which 
prevents F-actin assembly into stress fibres and impairs actin 
filament function.  
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Figure 9 – Sequence of events leading to tropomyosin 1 
phosphorylation by DAP kinase-I in the MAPKK pathway. PD 
inhibits MAPKK which prevents tropomyosin 1 phosphorylation. 
Tropomyosin 1 phosphorylation is required for F-actin to 
assemble into stress fibres. Schematic derived from data in 
Houle et al. (2003) and Houle et al. (2007).  
 
G.2 Direct binding inhibition of tropomyosin  
Tropomyosin can also be inhibited directly, by the anti-
tropomyosin drug TR100 (Figure 10). Briefly, TR100 was 
identified in a screen against the tropomyosin isoforms 
Tm5NM1/2, that were shown to be the most abundant isoforms 
present in tumor cells and potentially necessary for tumor cell 
survival (Stehn et al. 2013). The screen was conducted by 
showing that, firstly, F-actin depolymerization (as a ratio of 
G:F actin) decreased with increasing Tm5NM1/2 saturation and, 
secondly, TR100 negates the ability of Tm5NM1/2 to confer F-
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actin stability. F-actin and Tm5NM1/2-coated F-actin, treated 
with TR100, showed similar rates of depolymerization. These 
results demonstrate that tropomyosin promotes actin stability 
and that directly inhibiting tropomyosin with TR100 reduces this 
stability. The effects of TR100 were shown to be dose dependent 
and most robust for Tm5NM1/2 containing actin filaments. 
However, TR100 works by binding to the 9d exon sequence of 
tropomyosins, at the protein level, and this sequence is present 
in other tropomyosin isoforms (Schevzov et al. 2011). Therefore, 
while TR100 shows selectivity for Tm5NM1/2, it can affect other 
tropomyosins as well. Indeed, while TR100 showed an initial 
preferential loss for Tm5NM1/2 containing F-actin, actin 
filaments containing other LMW and HMW tropomyosins were also 
unable to bundle into stress fibres at higher concentrations of 
TR100 or for longer incubation periods. In general, these 
results were observed after 24-hour incubation periods. Overall, 
this suggests that TR100 has the potential to inhibit various 
tropomyosins expressing the 9d exon sequence and that this 
inhibition results in actin filament disorganization and 
improper F-actin functioning.  
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Figure 10 – Structure of TR100 and predicted modelling for 
interaction with 9d exon sequence of tropomyosin. Image from 
Stehn et al. (2011). Originally published in Cancer Research. 
DOI: 10.1158/0008-5472.CAN-12-4501. 
  
 Tropomyosin can therefore be inhibited in two ways, by 
preventing its phosphorylation with PD or by directly binding it 
with TR100. Both anti-tropomyosin drugs affect tropomyosin-bound 
actin filaments and result in improper F-actin functioning, 
actin filament disorganization and a loss of F-actin stability. 
Actin filaments are affected because tropomyosin is inhibited. 
With respect to TR100, it was not shown whether actin filaments 
free of tropomyosin were affected by this drug (Stehn et al. 
2013). However, due to the binding of TR100 with tropomyosin, it 
is presumed that actin filament disorganization occurs because 
tropomyosin is inhibited. Within the spindle, actin localizes to 
kinetochore fibres where it contributes force production for 
chromosome movement during anaphase. If tropomyosin is present 
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in the spindle, inhibiting it with either PD or TR100 may affect 
spindle actin and therefore affect chromosome movement during 
anaphase or other actin associated functions in the spindle.  
H. Tropomyosin in the spindle 
Tropomyosin has recently been localized in the mitotic spindle 
of Drosophila S2 cells (Goins and Mullins 2015). Briefly, these 
cells expressed three cytoskeletal tropomyosin isoforms 
including the isoform Tm1J, which is a HMW TPM1 gene product 
(Schevzov et al. 2011). Successfully transformed cells 
expressing eGFP-TM1J, showed Tm1J localization to specific 
regions of the mitotic spindle (Figure 11). Briefly, Tm1J 
localized to centrosomes during prophase and throughout 
metaphase. It also localized to kinetochores during metaphase 
and through early anaphase, where it remained as kinetochores 
moved poleward. During mid to late anaphase, Tm1J localized to 
the spindle midzone and central spindle areas. Although this was 
not discussed by the authors, faint outlines of the spindle and 
kinetochore fibres could also be seen in some images.  
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Figure 11 – Tropomyosin localization to the spindle in 
Drosophila S2 cells during mitosis. Tropomyosin Tm1J localizes 
to centrosomes (white arrow) and kinetochores (white arrow 
heads) during metaphase and remains at the kinetochores during 
early anaphase. In later anaphase, Tm1J localizes to the spindle 
midzone (yellow arrow) and central spindle (yellow arrow) areas. 
Image from Goins and Mullins (2015). Originally published in 
Molecular Biology of the Cell. DOI: 10.1091/mbc.E14-12-1619. 
 
In trying to elucidate the functional mechanism of Tm1J, 
two mutant proteins were generated to test whether troponin or 
phosphorylation are involved. Firstly, two residues were mutated 
in the putative troponin-T binding site. These mutants had 
similar localization of wild-type expressing cells; however, 
they had abnormal mitoses with kinetochore attachment defects, 
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unfocused spindle poles, delayed anaphase progression and 
missegregated chromosomes. Secondly, mutating the 
phosphorylation site on Tm1J, so that it could no longer be 
phosphorylated, did not affect Tm1J localization or proper 
spindle functioning. Together, these data suggest that 
tropomyosin localizes to the spindle, in particular to 
centrosomes and kinetochores during metaphase through early 
anaphase, and that it may function through a mechanism involving 
troponin.        
I. Crane-fly spermatocytes provide an excellent model for 
studying meiotic processes and cytoskeletal components  
Crane-fly (Nephrotoma suturalis (Loew)) primary spermatocytes 
provide an excellent model for studying the spindle and for 
illustrating chromosome movement. There are several reasons for 
choosing crane-flies to study the events of meiosis (Forer 
1982b) and these will be discussed here briefly. Firstly, crane-
flies can be easily reared in lab and cells can be obtained from 
suitable animals at any time throughout the year. Secondly, the 
cells within a single testis are synchronous, meaning that they 
enter the same divisional stage at more or less the same time. 
This is beneficial for studying the spindles at particular 
stages of division such as metaphase or anaphase. Thirdly, 
because there are small numbers of chromosomes, movements of 
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individual chromosomes can be easily followed throughout 
division under phase-contrast light microscopy.  
Primary spermatocytes are obtained from the testes of 
fourth-instar male larvae. The cells are comprised of three 
autosomal bivalents and two univalent sex chromosomes that 
undergo a reductional meiosis-I division (Forer 1980). The 
anaphase movements of the bivalents and univalents occur 
sequentially. During anaphase A, autosomal bivalents separate 
and move toward their respective spindle poles as spindle fibres 
shorten. During anaphase B, the spindle elongates and each of 
the sex-chromosome univalents moves toward a spindle pole (Yin 
and Forer 1996). The sex chromosomes exhibit amphitelic 
orientation, with kinetochore fibres extending to each pole, and 
display distance segregation, meaning that they are unpaired and 
unconnected and yet separate to opposite spindle poles (Forer et 
al. 2013). Several distinct measurements including kinetochore-
to-pole, kinetochore-to-equator, inter-kinetochore and inter-
polar distances can be plotted as functions of time. Therefore, 
chromosome movement can be well characterized. In addition, 
various experiments have been performed in crane-fly primary 
spermatocytes which have helped to elucidate the mechanisms of 
chromosome movement. For example, actin and myosin have been 
implicated as force producers for chromosome movement in crane-
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fly primary spermatocytes (reviewed in Forer et al. 2003). 
Therefore, these cells provide a good model for investigating 
other actomyosin associated proteins, such as tropomyosin. To my 
knowledge, no prior attempts have been made to localize or test 
the possible roles of tropomyosin during anaphase chromosome 
movement.  
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Possible Roles for Tropomyosin During 
Anaphase Chromosome Movement  
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Introduction 
The mitotic or meiotic spindle assembles during cell division in 
order to partition replicated or homologous chromosomes of a 
single cell into two daughter cells (Gadde and Heald 2004). 
Ensuring the proper segregation of genetic material is essential 
for producing viable daughter cells that contain the correct 
type and amount of DNA needed to carry out their functions. 
Understanding the mechanisms involved in chromosome movement 
during cell division contributes to understanding how genetic 
material is properly distributed into two daughter cells.  
Microtubules are the major structural components of the 
spindle. Since their discovery in kinetochore fibres, many 
functional models have proposed that microtubules, along with 
microtubule associate proteins, produce the force for chromosome 
movement (Forer et al. 2003). Currently, the Flux and the Pac-
Man models are the most commonly described mechanisms of force 
production for chromosome movement. These models differ with 
respect to how microtubules produce force; however, they both 
propose that microtubules and their motor proteins alone are 
responsible for moving chromosomes (e.g. Cassimeris et al. 1987, 
Mitchison 1988, Sharp et al. 2000, Rogers 2005). In general, 
these models suggest that microtubule depolymerization at the 
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pole (the Flux model) or at the kinetochore (the Pac-Man model) 
generate the force that moves chromosomes during cell division. 
However, other functional proteins, such as actin and 
myosin, have also been identified in the spindle and they have 
been implicated as force producers for chromosome movement. 
Actin and myosin are structural components of both mitotic and 
meiotic spindles (reviewed in Forer et al. 2003, Sheykhani et 
al. 2013). In particular, these proteins, as well as the muscle 
protein titin (Fabian et al. 2007), are present along the 
kinetochore fibres where they colocalize with microtubules and 
are involved in chromosome movement during anaphase. For 
example, anti-actin drugs such as cytochalasin D (CD) and 
latrunculin (Lat) as well as anti-myosin drugs such as 2,3-
butanedione 2-monoxime (BDM) and ML-7 have all been shown to 
slow or stop chromosome movement when added during anaphase 
(Forer and Pickett-Heaps 1998, Silverman-Gavrila and Forer 2001, 
Xie and Forer 2008, Sheykhani et al. 2013). This suggests that 
actin and myosin contribute to producing the force that moves 
chromosomes during anaphase. The mechanism through which spindle 
actin and myosin produce force has yet to be determined. In 
order to elucidate how actin and myosin may function in the 
spindle, it is helpful to understand how these proteins function 
in other cytoskeletal systems.  
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Actin and myosin produce contractile force in muscle cells 
(Huxley 1969). Briefly, actin filaments slide past myosin 
filaments by cross-bridge cycling which generates the force that 
causes muscles to contract. In striated muscle, the actomyosin 
interactions are regulated by tropomyosin and troponin (reviewed 
in Squire 1997). By binding along actin filaments, tropomyosin 
mediates the actomyosin interactions and thereby mediates force 
production. Tropomyosin also binds along actin filaments in non-
muscle cells where it confers structural and functional 
properties to actin filaments (reviewed in Cooper 2002, Gunning 
et al. 2015). In non-muscle cells, tropomyosin provides actin 
filament stability, alters actin filament polymerization and 
regulates actin-binding protein interactions. For example, 
tropomyosin localizes to the leading edges of lamellipodia where 
it is proposed to alter actin-binding protein interactions and 
thereby regulate actin filament polymerization (Hillberg et al. 
2006). In yeast, tropomyosin is associated with actin filament 
stability and genetic manipulation studies have shown that actin 
requires tropomyosin to form actin cables (Liu and Bretscher 
1989). Generally, tropomyosin is thought to confer these 
functions to actin filaments through the nature in which it 
binds along the actin filaments. In consideration that 
tropomyosin plays a role in both muscle and non-muscle cells, 
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where it is associated with actin filaments, it is worthwhile 
investigating whether tropomyosin is also involved in the 
spindle.  
A recent study has shown that tropomyosin localizes to the 
spindle of Drosophila S2 cells (Goins and Mullins 2015). An 
isoform of tropomyosin, known as Tm1J, was observed 
predominantly at the centrosomes and at the kinetochores during 
metaphase and early anaphase, as well as at the central spindle 
and mid-body during late anaphase. These data are evidence that 
tropomyosin localizes to the spindle. Furthermore, when putative 
troponin binding sites on tropomyosin were mutated, cells 
displayed abnormal mitoses, with respect to chromosome division. 
This suggests that tropomyosin may function in the spindle 
through a tropomyosin-troponin mechanism similar to striated 
muscle. However, the exact functional mechanism of spindle 
tropomyosin has not been determined and whether tropomyosin is 
present in other spindles has not been investigated.  
The purpose of my thesis was to test the possible roles of 
tropomyosin during anaphase chromosome movement in crane-fly 
primary spermatocytes. Actin and myosin are involved in anaphase 
chromosome movement in these cells; therefore, they provide good 
models to investigate tropomyosin. The objectives of my research 
were to localize spindle tropomyosin and test whether it plays a 
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role during anaphase chromosome movement. Briefly, this was 
accomplished by treating live cells with inhibitory drugs 
against tropomyosin as well as by staining for tropomyosin at 
various stages of cell division. Two inhibitory drugs against 
tropomyosin were tested. Firstly, cells were treated with PD 
098059 (PD). PD is a selective inhibitor against MAPKK, which 
prevents the downstream phosphorylation of tropomyosin (Houle et 
al. 2013, Houle et al. 2007). Cells were also treated with 
TR100. TR100 is a selective inhibitor against tropomyosin, that 
binds directly to different tropomyosin isoforms containing the 
9d exon sequence (Schevzov et al. 2011, Stehn et al. 2013). 
Tropomyosin inhibition by either PD or TR100, generally after 
incubation periods of one hour, result in disrupted actin 
filament organization and degraded actin filament function. Two 
different antibodies were used to stain for tropomyosin, since 
the isoform specificity of spindle tropomyosin was not known. 
TM311 is specific for the 1a exon sequence of high molecular 
weight tropomyosins (Schevzov et al. 2011) and shares antigen 
sequence homology with Drosophila tropomyosins. TM311 binds to 
tropomyosin in the spindles of Drosophila S2 cells (Goins and 
Mullens 2015). TM5NM1/2 is specific for the 9d exon sequence of 
low molecular tropomyosins (Schevzov et al. 2011). TR100 and 
TM5NM1/2 may share antigen specificity. Briefly, PD altered 
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movement in approximately 70% of the chromosomes followed during 
anaphase while TR100 altered movement in approximately 33% of 
the chromosomes followed during anaphase. Tropomyosin was also 
observed at the centrosomes and along the kinetochore fibres 
with both TM311 and TM5NM1/2. Overall, the results suggest that 
tropomyosin localizes to the meiotic spindle of crane-fly 
primary spermatocytes where it may serve functional roles during 
anaphase chromosome movement.  
Future experiments should investigate the levels of 
tropomyosin phosphorylation along kinetochore fibres as well as 
treating cells prior to anaphase onset. For example, it would be 
worthwhile to test the level of tropomyosin phosphorylation 
following PD treatment, to see whether chromosome movement is 
altered when phosphorylation levels are reduced. Furthermore, 
treating cells prior to anaphase onset may allow more time for 
the drugs, specifically TR100, to permeate the cell and inhibit 
tropomyosin along the kinetochore fibres. There is indication 
from other cytoskeletal effects of TR100 that suggest the drug 
may take a few minutes to affect actin-containing filaments in 
crane-fly primary spermatocytes. Treating cells prior to 
anaphase onset may allow more time for the drug to inhibit 
tropomyosin along kinetochore fibres before chromosomes reach 
the spindle poles.  
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Materials and Methods 
Crane fly stock  
Crane flies (Nephrotoma suturalis (Loew)) were reared in lab 
according to the methods described in Forer (1982b). Briefly, 
adult crane flies were kept in a Plexiglass cage where they 
copulated. Females laid their eggs onto small plastic petri dish 
bottoms lined with moist papier-mâché which were collected every 
3-4 days. Lightly toasted nettle leaves were pulverized by hand 
into a fine powder and sprinkled onto the papier-mâché with the 
eggs. The petri dishes were then covered with lids. Larvae 
hatched approximately 6-8 days later. They were kept in the 
small petri dishes for approximately 9-10 days before being 
transferred to larger petri dishes. Larvae were fed with toasted 
nettle leaves every 3-4 days. Pupae began to appear 
approximately one month after hatching. They were collected, 
rinsed with water and transferred to a crystallizing dish lined 
with moist papier-mâché which was placed in the Plexiglass cage. 
Adults emerged approximately 5-6 days later. Pupae dehydrated 
and died if the papier-mâché was not kept moist.  
Larval selection 
Fourth-instar male larvae were chosen for dissections. Male and 
female larvae have no external features to distinguish them 
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(Forer 1982b) so males could not be chosen with complete 
accuracy. However, within any given dish, males tended to be 
shorter and/or thinner than females, so they could be chosen 
with reasonable accuracy. Fourth-instar males were chosen based 
on fat-body content, which is a good indicator of developmental 
stage (Forer 1982b). I found that testes with the greatest 
number of dividing spermatocytes came from fourth-instar males 
whose body fat was opaque and disguised almost all of the 
digestive tract.   
Solutions  
Insect Ringer’s solution [0.13 M NaCl, 5 mM KCl, 1.5 mM CaCl2 and 
3 mM buffer (KH2PO4 and Na2HPO4•7H2O, pH 6.8); final pH 6.8] was 
used at room temperature. This Ringer’s solution was originally 
made for Drosophila (Ephrussi and Beadle 1936) but is used for 
crane-flies with the addition of buffer. It was stored in the 
refrigerator and prepared every few weeks from 10X and 20X stock 
solutions which were all kept frozen. Fibrinogen solution was 
prepared daily by dissolving bovine fibrinogen (MP Biomedicals, 
LLC) in Insect Ringer’s (10 mg: 1 mL). Thrombin solution was 
prepared by dissolving thrombin (Sigma) in Insect Ringer’s at a 
concentration of 100 units per 2 mL stored in aliquots of 
approximately 70 μL at -80˚C. One aliquot was used for a few 
weeks, during this time it would be stored at -4˚C after use.  
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Prior to use, the aliquot was allowed to thaw and, like the 
fibrinogen solution, it was kept on the work bench and used at 
room temperature. PD 098059 (PD) (LC Laboratories) was dissolved 
in dimethyl sulfoxide (DMSO) at a concentration of 85 mM and 
stored in aliquots of 3 μL and 6 µL at -30˚C. Prior to use, an 
aliquot of PD was allowed to thaw and then diluted in 5 mL of IR 
to give final concentrations of 50 μM (from 3 μL) or 100 μM 
(from 6 µL). TR100 (Sigma) was dissolved in DMSO at a 
concentration of 10 mM and stored at -4˚C. Prior to use, 
different volumes ranging from 12 μL to 50 μL were diluted in 5 
mL of IR to give final concentrations ranging from 25 μM to 100 
μM. Phosphate buffered saline (PBS) 10X stock [1.31 M NaCl, 
0.051 M Na2HPO4, 0.016 M KH2PO4; final pH 7.0] was made every few 
weeks and stored in the refrigerator. Before use, PBS was 
diluted in ddH2O to 1X concentration. 
Live cell preparations  
Living primary spermatocytes were obtained from crane flies as 
described in Forer and Picket-Heaps (1998). Briefly, testes were 
dissected out of fourth-instar male larvae and placed under 
Halocarbon oil. An individual testis was then rinsed in three 
drops of Insect Ringer’s that were placed on a plastic petri 
dish lid.  In the last drop of Insect Ringer’s, any remaining 
fat attached to the testis was removed with stainless steel 
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forceps. A drop of approximately 2-3 μL of fibrinogen solution 
was placed on a flamed coverslip and the testis was transferred 
to the drop of fibrinogen, pierced with a stainless-steel needle 
and the cells that emerged were spread around the coverslip so 
that the cells were evenly distributed. Shortly after, an equal 
volume of thrombin solution was spread over the fibrinogen and a 
fibrin clot was allowed to form for about 20 seconds under a 
petri dish lid to prevent evaporation. The coverslip was then 
inverted onto a stainless-steel perfusion chamber that was 
filled with Insect Ringer’s and the chamber was sealed with a 
molten mixture of 1:1:1 Vaseline, lanolin and paraffin. The 
perfusion chamber was connected to input and output tubes which 
allowed solutions of Insect Ringer’s, DMSO or diluted drugs to 
be perfused through.  
Phase-contrast light microscopy and data analysis 
Prometaphase-I or metaphase-I cells were chosen. Stage was 
determined by the chromosome shape and alignment, as well as the 
spindle shape. As cells approached anaphase, chromosomes aligned 
at the equator and the spindle became outlined by highly 
refractive mitochondria. A few minutes after anaphase onset, as 
separating half-bivalents moved toward opposite spindle poles, a 
solution containing diluted PD or TR100 or an equal volume of 
DMSO was perfused into the chamber and bathed all of the cells 
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held in the fibrin clot. The highest concentration of DMSO was 
0.5%. Control cells were perfused regularly with Insect 
Ringer’s.  
Cells were observed and recorded with phase-contrast light 
microscopy using a Nikon 100x oil immersion objective (NA, 1.3). 
Images were recorded on DVD discs in real time and time-lapsed 
avi files were generated with VirtualDub freeware 
(www.virtualdub.org). Kinetochore-to-pole, kinetochore-to-
equator and interkinetochore distances were measured using 
Winimage software and movement graphs were generated by plotting 
the distances versus time (SlideWrite).    
Lysing and fixation  
The lysing, fixing and staining procedures were based on those 
described by Fabian and Forer (2005). Briefly, cells that were 
recorded during anaphase were lysed [100 mM piperazineN,N-bis(2-
ethanesulfonic acid) [PIPES], 10 mM EGTA, 5mM MgSO4, NP40 2%, 
DMSO 5%] and then fixed with 0.2% glutaraldehyde in PBS. Cells 
were lysed by perfusing lysis buffer into the chamber and then 
removing and submerging the coverslip in more lysis buffer or by 
directly removing and submerging the coverslip in lysis buffer 
from the perfusion chamber. After variable amounts of time in 
lysis buffer (between approximately 20-60 minutes) the cells 
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were then fixed for 6 minutes [0.2% glutaraldehyde in PBS], 
washed in PBS (three times for 5 minutes each), kept for 10 
minutes in sodium borohydride [1mg/ml in PBS] and then washed in 
PBS (once quickly and then twice for 5 minutes each).  The fixed 
preps were then stored at 4˚C in PBS-glycerol 1:1 (v/v) until 
they were ready to be stained.  
Antibody staining  
Preps were double stained for tubulin and tropomyosin. The best 
results were obtained when tropomyosin was stained first.   
Microtubules were stained with YL ½ rat monoclonal antibody 
against tubulin (1:100) (Invitrogen) followed by Alexa 594 goat-
anti-rat immunoglobulin IgG (1:200) (Invitrogen). Tropomyosin 
was stained with TM311 mouse monoclonal antibody against 
tropomyosin (1:200, 1:100 or 1:50) (Abcam Canada) followed by 
Alexa 488 goat-anti-mouse immunoglobulin IgM (1:150 or 1:100) 
(Invitrogen). TM311 is specific for the 1a exon sequence of high 
molecular weight tropomyosins (Schevzov et al. 2011) which 
shares sequence homology with Drosophila isoforms (amino acid 
sequence of antibody immunogen: LDKENALDRAEQAEADKKAA). 
Tropomyosin was also stained with TM5NM1/2 sheep polyclonal 
antibody against tropomyosin (1:100 or 1:50) (EDM Millipore) 
followed by reconstituted Alexa 488 donkey-anti-sheep 
immunoglobulin IgG (H&L) (1:50 or 1:100) (Cedarlane: Novus 
54 
 
Biologicals). TM5NM1/2 is specific for the 9d exon sequence of 
low molecular tropomyosins (Schevzov et al. 2011). All 
antibodies were diluted in PBS. The incubation time for each 
antibody was 1 hour at room-temperature, except for primary 
antibodies against tropomyosin which were incubated for 2 hours. 
Prior to adding an antibody, preps were washed with 0.1% Triton 
X-100 to facilitate flow. Preparations were kept in the dark 
during the incubation periods to prevent light inactivation of 
the fluorochromes. Coverslips were mounted in Mowiol 
(Calbiochem) solution (Osborn and Weber 1982) containing 
paraphenylene diamine as antifading agent (Fabian and Forer 
2005), and stored at 4 °C in the dark until viewed in the 
confocal microscope.  
 Some preps were also triple stained for tubulin, actin and 
tropomyosin. Microtubules were stained with YL ½ rat monoclonal 
antibody against tubulin (1:100) (Invitrogen) followed by Alexa 
633 goat-anti-rat immunoglobulin IgG (1:200) (Invitrogen). Actin 
was stained with 0.43 µM or 0.66 uM Alexa 568 phalloidin 
(Invitrogen). Tropomyosin was stained with TM311 mouse 
monoclonal antibody against tropomyosin (1:100 or 1:50) (Abcam 
Canada) followed by Alexa 488 goat-anti-mouse immunoglobulin IgM 
(1:150 or 1:100) (Invitrogen). Tropomyosin was also stained with 
TM5NM1/2 sheep polyclonal antibody against tropomyosin (1:100 or 
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1:50) (EDM Millipore) followed by reconstituted Alexa 488 
donkey-anti-sheep immunoglobulin IgG (H&L) (1:50 or 1:100) 
(Cedarlane: Novus Biologicals). The same staining procedure was 
followed for triple staining as it was for double staining, 
except that preps were incubated with phalloidin for 1 hour 
after staining for tubulin and tropomyosin.  
Confocal microscopy and image processing  
Cells were observed with different confocal microscopes. 
Firstly, the Olympus Fluoview 300 confocal microscope, with 
argon laser at 488 nm and HeNe laser at 543 and 660 nm, using an 
Olympus Plan Apo 60X oil immersion objective (NA, 1.4). 
Secondly, the LSM 700 Zeiss Observer Z.1 confocal microscope, 
with lines at 488, 555 and 639, using a Zeiss EC Plan-NEOFLUAE 
40X oil immersion objective (NA, 1.3). Lastly, some images were 
collected on an Olympus Fluoview 3000 confocal microscope using 
a 60X oil immersion objective (NA, 1.35) which was temporarily 
available at York University (Toronto, Canada). The images were 
further processed using Image J software (available at 
http://rsb.info.nih.gov/ij/). 
Triple stained images have not been included because we 
were unable to resolve issues with the LSM 700 Zeiss Observer 
Z.1 confocal microscope. Negative controls showed images in 
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channels for which there were no fluorescent antibodies or 
phalloidin. For example, images appeared in the Alexa 568 
channel when no Alexa 568 phalloidin had been added. This cannot 
be explained by secondary antibody cross reaction. I sought help 
from different confocal microscope technicians but was unable to 
solve the problem. Therefore, only double stained images have 
been included.  
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Results 
Control divisions 
Crane-fly primary spermatocytes have three autosomal bivalents 
and two univalent sex chromosomes (Forer 1980, Forer 1982b, Yin 
and Forer 1996). During anaphase-I, the autosomal bivalents 
separate into two half-bivalents that move toward opposite 
spindle poles as their kinetochore fibres shorten. Once the 
autosomal half-bivalents reach the spindle poles, the sex-
chromosome univalents move toward opposite spindle poles as the 
spindle elongates. My experiments focused on autosomal half-
bivalent movement.  
Chromosome movement was analyzed by plotting the 
kinetochore to pole or kinetochore to equator distances over 
time (Figure 12) or the interkinetochore distance over time 
(Figure 13). Anaphase speeds were then calculated from the 
slopes of the movement graphs. In order to calculate the speeds 
of individual kinetochores in which the interkinetochore 
distance was measured over time, the separation speed was 
divided by two. Speeds varied considerably between pairs of 
autosomal half-bivalents, within the same cell and between cells 
(Dietz 1972). On average, kinetochores moved poleward with a 
speed of 0.5±0.2µm/min (Figure 14). Sometimes, as kinetochores 
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approached the spindle poles they slowed down to approximately 
25% of their initial anaphase speed (n=13/47).  
 
 
 
Figure 12 – Illustrating constant poleward velocity during 
anaphase in Insect Ringer’s. Kinetochore to equator distances 
were plotted over time for a pair of separating half-bivalents. 
The top kinetochore (blue) moves poleward at 0.4µm/min and the 
bottom kinetochore (yellow) moves poleward at 0.5µm/min. This 
graph is an example of one of the many control divisions that 
were observed in Insect Ringer’s.   
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Figure 13 – Illustrating constant poleward velocity during 
anaphase in Insect Ringer’s. The interkinetochore distance was 
plotted over time for a pair of separating half-bivalents. The 
kinetochores move poleward with a separation speed of 0.5µm/min. 
This graph is an example of one of the many control divisions 
that were observed in Insect Ringer’s.   
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Figure 14 – Average control speeds during anaphase in Insect 
Ringer’s. Kinetochores moved poleward with an average initial 
speed of 0.5±0.2µm/min (n=47). Sometimes, as kinetochores 
approached the spindle poles, they slowed down to approximately 
28% of their initial anaphase speed (n=13/47). Time indicates 
minutes after anaphase onset. Asterisks indicate significant 
differences in speed (*, p<0.05). Error bars represent SD. 
[n=number of kinetochores].  
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Anaphase chromosome movement following treatment  
To test whether tropomyosin is involved in anaphase chromosome 
movement, live cells were treated with inhibitory drugs against 
tropomyosin during anaphase and chromosome movement was analyzed 
with movement graphs. Similar methods have been used in crane-
fly primary spermatocytes to test the roles of actin and myosin 
during anaphase chromosome movement (Forer and Pickett-Heaps 
1998, Silverman-Gavrila and Forer 2001, Xie and Forer 2008, 
Sheykhani et al. 2013). When added during anaphase, these drugs 
slow, stop or slow and then stop chromosome movement. It was 
predicted that if tropomyosin is also involved in anaphase 
chromosome movement, then inhibitory drugs against tropomyosin 
would alter chromosome movement.  
 Briefly, cells were chosen in the prometaphase-I to 
metaphase-I stage of division. Stage was determined by the 
chromosome shape and alignment as well as the spindle shape. 
After anaphase onset, as autosomal half-bivalents moved toward 
their respective spindle poles, cells were treated with PD, 
TR100 or an equal volume of DMSO. Movement graphs were then 
generated by plotting the kinetochore to pole or kinetochore to 
equator distances over time or the interkinetochore distance 
over time. Anaphase speeds for individual kinetochores both 
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prior to and following treatment were calculated from the slopes 
of the movement graphs.  
Table 1 provides a summary of the average relative anaphase 
speeds following DMSO, PD and TR100 treatment and Table 2 
provides a summary of the number of kinetochores showing 
different effects following DMSO, PD and TR100 treatment. Data 
were combined for the different concentrations within each 
treatment because the kinetochores reacted similarly between 
concentrations. Overall, over approximately 70% of the 
kinetochores followed during anaphase were altered following PD 
treatment, while approximately 33% of the kinetochores followed 
during anaphase were altered by TR100 treatment. In general, 
kinetochores that were affected by PD or TR100 treatment either 
slowed, slowed and then stopped or stopped following treatment.   
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Table 1 – Average relative anaphase speeds following DMSO, PD 
and TR100 treatments. Relative speeds for individual 
kinetochores were calculated as percentages of the initial 
anaphase speed of the kinetochore prior to treatment (Tx). Some 
kinetochores were analyzed after washing out PD (speed after 
wash out). Times indicate minutes after anaphase onset. 
[n=number of kinetochores]. 
Treatment Chromosome 
movement  
Number 
of kt. 
 
Average relative speed (% initial speed) 
Speed 
following 
Tx 
Second 
speed in 
Tx 
Resumed 
speed in 
Tx 
Speed 
after 
wash out 
DMSO  
[0.25% - 
0.5%] 
No effect 19 
 
102.6± 
50.5 
   
Time 
(min) 
3.8±2.1    
PD 
[50 µM and 
100 µM] 
 
n=63 
No effect 
18 
 
99.4±24.6 
  
97.8±89.8 
[n=7] 
 
Time 
(min) 
4.8±1.3 
  
13.8±0.5 
Slowed 
19 
 
47.9±13.4 
 
114.7 
[n=2] 
60.7±13.2 
[n=5] 
 
Time 
(min) 
3.5±0.8 
 
17 
10.6± 
1.3 
Slowed 
then 
stopped 
9 
 
53.4±15.1 Stopped 
53.6±37.4 
[n=6]  
 
Time 
(min) 
1.9±0.3 6.6±4.8 11.8±22.2 
 
Stopped 
17 
 
Stopped 
 
123.0± 
92.2 
[n=14] 
132.3± 
105.2 
[n=7] 
 
Time 
(min) 
4.3±2.1 
 
15.6± 5.4 
21.8± 
3.95 
TR100  
[25 µM – 
100 µM] 
 
n=81 
No effect 
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114.3± 
49.2    
 
Time 
(min) 
3.8±1.6 
   
Slowed 
20 
 
43.5±14.3 
 
91.8±17.9 
[n=7]  
 
Time 
(min) 
3.4±1.5 
 
9.2±2.7 
 
Stopped 
3 
 
Stopped 
 
196.5± 
134.8  
 
Time 
(min) 
3.7±0.6 
 
22±11.3 
 
Delayed 
stop 
4 
 
165.4± 
69.2 
Stopped 
208.2± 
67.5  
 
Time 
(min) 
4.5±0.6 8.8±0.5 20.2±2.6 
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Table 2 – Summary of chromosome movements after control (DMSO) 
and drug treatments (PD and TR100) added during anaphase. The 
numbers of kinetochores having different effects following DMSO, 
PD and TR100 treatment have been included as well as their 
relative percentages (in brackets). The relative percent of 
kinetochores were calculated for each treatment, by dividing the 
number of kinetochores having a particular effect over the total 
number of kinetochores following that treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment 
Total number 
of 
kinetochores 
Chromosome movement following treatment  
[number of kinetochores] 
No effect Slowed Slowed 
then 
stopped 
Stopped  Delayed 
stop 
DMSO  
[0.25% - 
0.5%] 
19 19  
(100%) 
    
PD  
[50 µM 
and 100 
µM] 
63  18  
(28.6%) 
19  
(30.2%) 
9 
(14.3%)  
17 
(27%)  
 
TR100  
[25 µM - 
100 µM] 
81 54  
(66.7%) 
20 
(24.7%) 
 3 
(3.7%) 
4 
(4.9%) 
65 
 
DMSO treatment 
In total, ten cells were treated with DMSO [0.25% to 0.5%] and 
19 kinetochores were followed during anaphase. DMSO did not 
affect chromosome movement when added during anaphase (Tables 1 
and 2). An example graph following DMSO treatment has been 
included (Figure 15). Previous studies in crane-fly primary 
spermatocytes have also shown that Insect Ringer’s solution, 
containing up to 0.2% DMSO, had no effect on chromosome movement 
during anaphase (reviewed in Xie and Forer 2008).  
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Figure 15 – Illustrating chromosome movement following DMSO 
treatment. DMSO [0.25%] was added approximately 4 minutes after 
anaphase onset. Following treatment, chromosomes continued 
moving poleward with no observable change in speed.   
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PD treatment 
Cells were treated with PD at both low [50 µM] and high [100 µM] 
concentrations. In total, eighteen cells were treated with PD 
during anaphase and 63 kinetochores were followed. PD altered 
anaphase chromosome movement in over 70% of the kinetochores 
followed during anaphase (Table 2). Some kinetochores slowed to 
approximately 48% of their initial anaphase speed (n=19/63) 
(Figure 16). A graph illustrating slowed movement following PD 
treatment has been included (Figure 17). Kinetochores sometimes 
slowed and then stopped moving following PD treatment (n=9/63). 
These kinetochores slowed to approximately 53% of their initial 
anaphase speed before stopping (Figure 18). Most of these 
kinetochores resumed poleward movement while still in PD (n=6/9) 
with an average speed of approximately 54% of their initial 
anaphase speed. A graph illustrating slowed and then stopped 
movement following PD treatment has been included (Figure 19). 
Lastly, some kinetochores stopped moving following PD treatment 
(n=17/63) (Figure 20). Most of these kinetochores resumed 
movement while still in PD, with an average speed of 
approximately 123% of their initial anaphase speed (n=14/17). 
After wash out, the kinetochores continued moving poleward with 
an average speed of approximately 132% of their initial anaphase 
speed (n=9/17). A graph illustrating stopped movement following 
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PD treatment has been included (Figure 21). Overall, between 
cells and within the same cell, bivalents reacted differently to 
PD treatment. However, most partner half-bivalents reacted the 
same (n=50/63 kinetochores). In addition, many kinetochores 
increased in speed or resumed poleward movement while still in 
PD after slowing or stopping (n=22/45).              
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Figure 16 – Average speeds following PD treatment that slowed 
anaphase movement. Kinetochores moved with an average initial 
speed of 0.6±0.2µm/min (n=19). Following PD treatment [50 µM and 
100 µM] kinetochores slowed on average to 48% of their initial 
anaphase speed. After wash out, kinetochores moved with an 
average speed of approximately 61% of their initial anaphase 
speed (n=5). After slowing, one pair of partner kinetochores 
increased in speed while still in PD. Times indicate minutes 
after anaphase onset. Asterisks indicate significant differences 
in speed (*, p<0.05; **, p<0.05). Error bars represent SD. 
[n=number of kinetochores].  
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Figure 17 – Illustrating slowed chromosome movement following PD  
treatment. PD [100 µM] was added approximatley 4 minutes after 
anaphase onset. Immediately following PD treatment, kinetochore 
movement slowed. Prior to PD treatment, the kinetochores moved 
poleward with a separation speed of 1.2µm/min. Following PD 
treatment, the kinetochores moved poleward with a separation 
speed of 0.6µm/min.  
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Figure 18 – Average speeds following PD treatment that slowed 
and then stopped anaphase movement. Kinetochores moved with an 
average initial speed of 0.88±0.2µm/min (n=9). Following PD 
treatment [50 µM and 100 µM] kinetochores slowed on average to 
53% of their initial anaphase speed and then stopped moving 
poleward. Some of these kinetochores then resumed poleward 
movement with an average speed of 54% of their initial anaphase 
speed (n=6/9). Times indicate minutes after anaphase onset. 
Asterisks indicate significant differences in speed (*, p<0.05; 
**, p<0.05; ***, p<0.05; ****, p<0.05). Error bars represent SD. 
[n=number of kinetochores].     
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Figure 19 – Illustrating slowed and then stopped chromosome 
movement following PD  treatment. PD [100 µM] was added 
approximately 2 minutes after anaphase onset. Immediately 
following PD treatment, kinetochore movement slowed. Prior to PD 
treatment, the kinetochores moved poleward with a separation 
speed of 1.6µm/min. Following PD treatment, the kinetochores 
moved poleward with a separation speed of 0.7µm/min. 
Approximately 4 minutes after PD treatment, the kinetochores 
stopped moving poleward (yellow arrow). The kinetochores resumed 
movement approximately 10 minutes after PD treatment with a 
speed of 1.3µm/min (green arrow).   
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Figure 20 – Average speeds following PD treatment that stopped 
anaphase movement. Kinetochores moved with an average initial 
speed of 0.52±0.2µm/min (n=17). Following PD treatment [50 µM 
and 100 µM] kinetochores stopped moving poleward. Most of these 
kinetochores resumed poleward movement while still in PD, with 
an average speed of approximately 123% of their initial anaphase 
speed (n=14/17). After wash out, kinetochores moved with an 
average speed of approximately 132% of their initial anaphase 
speed. Times indicate minutes after anaphase onset. Asterisks 
indicate significant differences in speed (*, p<0.05; **, 
p<0.05; ***, p<0.05; ***, p<0.05). Error bars represent SD. 
[n=number of kinetochores].     
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Figure 21 – Illustrating stopped chromosome movement following 
PD  treatment. PD [50 µM] was added approximatley 5 minutes 
after anaphase onset. Immediately following PD treatment, 
kinetochores stopped moving poleward. The top kinetochore 
resumed poleward movement approximately 15 minutes after PD was 
added (green arrow) and the bottom kinetochore resumed poleward 
movement approximately 17 minutes after PD was added (orange 
arrow). Kinetochores resumed poleward movement before PD was 
washed out.  
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TR100 treatment 
Cells were treated with variable concentrations of TR100 ranging 
from 25 µM to 100 µM. In total, thirty-four cells were treated 
with TR100 during anaphase and 81 kinetochores were followed. In 
66% of the kinetochores followed during anaphase, TR100 did not 
affect chromosome movement (Table 2, Figure 22). A graph 
illustrating chromosome movement following TR100 treatment in 
which movement was unaffected has been included (Figure 23). In 
33% of the kinetochores following during anaphase, movement 
slowed or stopped following TR100 treatment (Table 2). Some 
kinetochores slowed to approximately 44% of their initial 
anaphase speed immediately following TR100 treatment (n=20/81) 
(Figure 24). Some of these kinetochores (n=7/20) then 
subsequently increased in speed while still in TR100 to 
approximately 92% of their initial anaphase speed. A graph 
illustrating slowed movement following TR100 treatment has been 
included (Figure 25). Some kinetochores stopped moving poleward 
immediately following TR100 treatment (n=3/81) (Figure 26). 
After stopping, these kinetochores resumed poleward movement 
while still in TR100, with an average speed of approximately 
196% of their initial anaphase speed. A graph illustrating 
stopped movement following TR100 treatment has been included 
(Figure 27). Lastly, some kinetochores continued moving poleward 
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after TR100 treatment but then stopped moving approximately 4 
minutes after treatment (n=4) (Figure 28). These kinetochores 
then resumed poleward movement with an average speed of 
approximately 208% of their initial anaphase speed. A graph 
illustrating this type of movement following TR100 treatment has 
been included (Figure 29). In general, partner half-bivalents 
reacted the same (n=68/81). TR100 did not consistently slow or 
stop chromosome movement at any concentration in which it was 
used.  
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Figure 22 – Average speed following TR100 treatment in which 
chromosome movement was unaffected. Kinetochores moved with an 
average initial speed of 0.54±0.2µm/min (n=54). Following TR100 
treatment [25 µM to 100 µM] kinetochores moved poleward with an 
average speed of approximately 114% of their initial anaphase 
speed. Time indicates minutes after anaphase onset. Error bars 
represent SD. [n=number of kinetochores].  
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Figure 23 – Illustrating chromosome movement that was unaffected 
following TR100 treatment. TR100 [40 µM] was added approximatley 
4 minutes after anapahse onset. Following treatment, chromosomes 
continued moving poleward with no observable change in speed.   
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Figure 24 – Average speeds following TR100 treatment that slowed 
anaphase movement. Kinetochores moved with an initial average 
speed of 0.84±0.3µm/min (n=20). Following TR100 [25 µM to 50 µM] 
kinetochores slowed on average to 44% of their initial anaphase 
speed. Some kinetochores then increased in speed to 
approximately 92% of their initial anaphase speed (n=7/20). 
Times indicate minutes after anaphase onset. Asterisks indicate 
significant differences in speed (*, p<0.05). Error bars 
represent SD. [n=number of kinetochores]. 
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Figure 25 – Illustrating slowed chromosome movement following 
TR100 treatment. TR100 [25 µM] was added approximately 1.5 
minutes after anaphase onset. Following treatment, kinetochore 
movement slowed. Prior to TR100 treatment, the top kinetochore 
moved with a speed of 1.5µm/min (blue) and the bottom 
kinetochore moved with a speed of 1.0µm/min (yellow). Following 
TR100 treatment, the top (red) and bottom (purple) kinetochores 
slowed to 0.4µm/min.  
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Figure 26 – Average speeds following TR100 treatment that 
stopped anaphase movement. Kinetochores moved with an initial 
average speed of 0.37±0.2µm/min (n=3). Following TR100 treatment 
[40 µM and 50 µM] the kinetochores stopped moving poleward. They 
resumed poleward movement with an average speed of 196% of their 
initial anaphase speed. Times indicate minutes after anaphase 
onset. Asterisks indicate significant differences in speed (*, 
p<0.05; **, p<0.05). Error bars represent SD. [n=number of 
kinetochores].    
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Figure 27 – Illustrating stopped chromosome movement following 
TR100 treatment. TR100 [40 µM] was added approximately 4 minutes 
after anaphase onset. Following treatment, kinetochores stopped 
moving poleward. The top kinetochore resumed movement 
approximately 24 minutes after TR100 treatment (blue arrow). The 
bottom kinetochore resumed movement approximately 20 minutes 
after anaphase onset (green arrow). The top kinetochore moved 
with an initial speed of 0.3µm/min (light blue) and resumed 
speed of 0.9µm/min (dark blue). The bottom kinetochore moved 
with an initial speed of 0.6µm/min (yellow) and resumed movement 
of 1.0µm/min (light green).  
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Figure 28 – Average speeds following TR100 treatment that had a 
delayed effect. Kinetochores moved with an initial average speed 
of 0.35±0.1µm/min (n=4). Immediately following TR100 treatment 
[25 µM to 50 µM] the kinetochores moved poleward with an average 
speed of 0.55±0.2µm/min. Approximately 4 minutes after 
treatment, the kinetochores stopped moving poleward. The stopped 
kinetochores then resumed poleward movement with an average 
speed of approximately 208% of their initial anaphase speed. 
Times indicate minutes after anaphase onset. Asterisks indicate 
significant differences in speed (*, p<0.05; **, p<0.05; ***, 
p<0.05). Error bars represent SD. [n=number of kinetochores].      
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Figure 29 – Illustrating chromosome movement that showed a 
delayed effect following TR100 treatment. TR100 [50 µM] was 
added approximatley 4 minutes after anaphase onset. Immediately 
following treatment, the kinetochores continued moving poleward. 
Approximately 3.5 minutes after TR100 treatment, the 
kinetochores stopped moving poleward and moved toward each 
other. The kinetochores resumed poleward movement approximately 
14 minutes after TR100 treatment.   
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Cytoskeletal effects following treatment  
Cytoskeletal effects including membrane blebbing, inhibition of 
cleavage furrow ingression and loss of actin fingers, were 
observed following treatment with TR100. In general, these 
effects were observed after chromosomes were near or at the 
spindle poles and they occurred in cells in which chromosome 
movement was either affected or unaffected.   
Membrane blebbing 
Membrane blebs occasionally appeared in cells after chromosomes 
reached the spindle poles, following treatment with 25 µM TR100 
(n=4/34) (Figure 30). Membrane blebs did not appear in control 
cells (n=35) or cells treated with PD (n=18).    
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Figure 30 – Membrane blebbing following TR100 treatment. This 
cell was treated with TR100 [25 µM] 2 minutes after anaphase 
onset (red arrow). Membrane blebbing was observed approximately 
15 minutes following TR100 treatment (yellow arrows). This cell 
did not cleave.  
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Cleavage furrows  
The contractile ring forms and cleavage furrows begin to ingress 
after autosomal half-bivalents reach the spindle poles in crane-
fly primary spermatocytes. In general, cleavage furrows ingress 
from both sides of the cell; however, unilateral cleavage 
furrows may appear in some cells in which ingression occurs from 
one side (Silverman-Gavrila and Forer 2001). Both symmetrical 
and asymmetrical cleavage furrow ingressions were counted here. 
In control conditions (Insect Ringer’s and DMSO), cleavage 
furrows were observed in over 77% (n=27/35) of the cells (Figure 
31). They were also observed in 60% (n=3/5) of cells in PD 
treatment and 85% (n=11/13) of cells following PD treatment but 
after wash out. In TR100 treatment, cleavage furrows were 
observed in only 21% (n=7/34) of cells. 
To account for the possibility that cleavage furrow 
initiation may have been delayed, as opposed to being inhibited, 
cells in which cleavage furrows were not observed following 
TR100 treatment were recorded, on average, for longer periods of 
time than the average time required for cleavage furrows to 
appear in control conditions (IR and DMSO) or in TR100 (Figure 
32). In one cell treated with 25 µM TR100, an asymmetric 
cleavage furrow appeared and ingressed for approximately 1.5-2 
minutes, before regressing (Figure 33).   
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Figure 31 – Relative percent of cells with cleavage furrow 
ingression in different treatments. Relative percentages were 
calculated as the number of cells showing cleavage furrow 
initiation divided by the total number of cells in each 
treatment. In control conditions, cleavage furrows appeared in 
77% of control cells (Insect Ringer’s and DMSO). While in PD [50 
µM and 100 µM], 60% of cells showed cleavage furrows. After 
washing out PD [50 µM and 100 µM], 84% of cells showed cleavage 
furrows. Cleavage furrows appeared on only 21% of cells in TR100 
[25 µM to 100 µM]. Asterisks indicate significant differences 
(*, p<0.05; **, p<0.05) calculated with Fisher’s exact test. 
[n=number of cells].  
 
89 
 
 
Figure 32 – Average time after anaphase onset that cleavage 
furrows begin to ingress (minutes). Bars represent the average 
time for cleavage furrows to appear after anaphase onset (green) 
or the average length of time that cells were recorded after 
anaphase onset where no cleavage furrow appeared (blue). 
Cleavage furrows appeared approximately 33.5±14.9 minutes after 
anaphase onset in control conditions (Insect Ringer’s and DMSO). 
In TR100, cleavage furrows appeared 34.4±11.5 minutes after 
anaphase onset. Cells treated with TR100, in which no cleavage 
furrows were observed, were recorded, on average, for 43±19.1 
minutes after anaphase onset. Error bars represent SD. [n=number 
of cells].   
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(a)  
(b)  
Figure 33 – Cleavage furrow attempt in TR100. (a) Typical 
cleavage furrow ingression in control conditions. This cleavage 
furrow appeared approximately 20 minutes after anaphase onset 
(red arrow) and continued to ingress for several (>4) minutes. 
(b) This cell was treated with TR100 [25 µM] 4 minutes after 
anaphase onset.  Approximately 50 minutes after anaphase onset a 
cleavage furrow appeared (red arrow). The cleavage furrow 
ingressed for approximately 1.5-2 minutes before regressing 
(yellow arrow). The cell was recorded for 60 minutes after 
anaphase onset and did not cleave.  
91 
 
Actin fingers 
In crane-fly primary spermatocytes, bunches of actin filaments 
are often seen protruding at the spindle poles and these are 
referred to as “actin fingers” (Xie and Forer 2008). Following 
TR100 treatment, at various concentrations [25 µM to 100 µM], 
actin fingers often changed shape and eventually disappeared 
(Figure 34). After variable amounts of time following TR100 
treatment, actin fingers began to appear thicker and shorter. 
The actin fingers became progressively compact and eventually 
disappeared at the spindle poles. This occurred in 25/29 cells 
treated with TR100, in which actin fingers were visible. Changes 
in the actin fingers could be seen as early as 2-3 minutes 
following TR100 treatment and gross changes appeared 
approximately 19.3±13 minutes after TR100 treatment. Actin 
fingers did not change in shape or lose integrity throughout 
cell division in control conditions (Insect Ringer’s and DMSO). 
Actin fingers were present in 4 cells treated with PD, and they 
did not change shape following PD treatment.    
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Figure 34 – Loss of actin fingers following TR100 treatment. 
This cell was treated with TR100 [100 µM] 6 minutes after 
anaphase onset (red arrow). Actin “fingers” at the spindle poles 
(blue arrows, Xie and Forer 2008) gradually changed shape and 
then disappeared following TR100 treatment. The “fingers” became 
more compact or thicker (white arrow) and then progressively 
shrunk or disappeared (yellow arrow). Chromosome movement was 
not significantly affected following TR100 treatment and the 
cell did not cleave.  
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Tropomyosin localization in the spindle  
Tropomyosin was stained with two different antibodies against 
different isoforms. To test for a range of possible tropomyosins 
in the spindle, two antibodies were chosen that have different 
isoform specificity, TM311 and TM5NM1/2. Tropomyosin localized 
at the spindle poles and along the kinetochore fibres of crane-
fly primary spermatocytes, as observed with both the TM311 and 
TM5NM1/2 antibodies. During prometaphase-I to anaphase-I, 
tropomyosin was observed at the spindle poles and along the 
kinetochore fibres (Figure 35, Figure 36 and Figure 37). In 
anaphase-I, tropomyosin was observed along kinetochore fibres 
attached to autosomal half-bivalents as well as the sex 
chromosome univalents. These data show that tropomyosin 
localizes to the meiotic spindles of crane-fly primary 
spermatocytes, particularly to the spindle poles and along 
kinetochore fibres closer to anaphase-I.  
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Figure 35 – Three different cells stained for tropomyosin in 
prometaphase-I to metaphase-I stages of cell division. Spindle 
microtubules have been stained with YL ½ rat monoclonal antibody 
against tubulin followed by Alexa 594 goat-anti-rat 
immunoglobulin IgG. (A) cell 1: tropomyosin was stained with 
TM311 mouse monoclonal antibody against tropomyosin (1:200) 
followed by Alexa 488 goat-anti-mouse immunoglobulin IgM 
(1:150). (B) cell 2: tropomyosin was stained with TM5NM1/2 sheep 
polyclonal antibody against tropomyosin (1:100) followed by 
reconstituted Alexa 488 donkey-anti-sheep immunoglobulin IgG 
(H&L) (1:50). (C) cell 3: tropomyosin was stained with TM311 
mouse monoclonal antibody against tropomyosin (1:100) followed 
by Alexa 488 goat-anti-mouse immunoglobulin IgM (1:100).  Images 
of cells 1 and 3 were taken with Olympus Fluoview 300 confocal 
microscope (60X oil immersion objective; NA, 1.4). Images of 
cell 2 were taken with Olympus Fluoview 3000 confocal microscope 
(60X oil immersion objective; NA, 1.35). Tropomyosin localizes 
to the spindle, along kinetochore fibres (white arrow) and at 
the spindle poles (arrowhead). Bars, 5 µm. 
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Figure 36 – Three different cells stained for tropomyosin in 
anaphase-I, as autosomal half-bivalents move toward spindle 
poles. Spindle microtubules have been stained with YL ½ rat 
monoclonal antibody against tubulin followed by Alexa 594 goat-
anti-rat immunoglobulin IgG. (A) cell 1 and (B) cell 2: 
tropomyosin was stained with TM311 mouse monoclonal antibody 
against tropomyosin (1:100) followed by Alexa 488 goat-anti-
mouse immunoglobulin IgM (1:100). (C) cell 3: tropomyosin was 
stained with TM5NM1/2 sheep polyclonal antibody against 
tropomyosin (1:100) followed by reconstituted Alexa 488 donkey-
anti-sheep immunoglobulin IgG (H&L) (1:50). Images were taken 
with Olympus Fluoview 300 confocal microscope (60X oil immersion 
objective; NA, 1.4). Tropomyosin localizes to the spindle, along 
kinetochore fibres (white arrow) and at the spindle poles 
(arrowhead). Bars, 5 µm. 
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Figure 37 – Three different cells stained for tropomyosin in 
prometaphase-I to anaphase-I stages of cell division. Spindle 
microtubules have been stained with YL ½ rat monoclonal antibody 
against tubulin followed by Alexa 594 goat-anti-rat 
immunoglobulin IgG. Tropomyosin was stained with TM311 mouse 
monoclonal antibody against tropomyosin (A, 1:200) (B, 1:200) 
(C, 1:100) followed by Alexa 488 goat-anti-mouse immunoglobulin 
IgM (A, 1:150) (B, 1:150) (C, 1:100). Images of were taken with 
LSM 700 Zeiss Observer Z.1 confocal microscope (40X oil 
immersion objective; NA, 1.3). Tropomyosin localizes to the 
spindle, along kinetochore fibres (white arrow) and at the 
spindle poles (arrowhead). Bars, 5 µm. 
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Non-constant poleward velocity during anaphase  
In the cells of some testes, autosomal half-bivalents moved with 
non-constant poleward velocity during anaphase in Insect 
Ringer’s. This occurred on a per animal, per testis basis, 
meaning that all of the cells within a single testis displayed 
non-constant poleward velocity. These kinetochores began 
anaphase with normal poleward velocities and after variable 
amounts of time, but before reaching the spindle poles, the 
kinetochores either slowed (n=13/72) or stopped moving (n=12/72) 
(Figure 38). After slowing, some kinetochores subsequently 
increased in speed to approximately 88% of their initial 
anaphase speed (n=11/13) or, after stopping, kinetochores 
resumed poleward movement at approximately 109% of their initial 
anaphase speed (n=12/12). A movement graph illustrating 
temporarily stopped movement during anaphase in Insect Ringer’s 
has been included (Figure 39). Table 3 provides a summary of the 
average anaphase speeds in Insect Ringer’s. 
 In order to account for this ‘abnormality’, control cells 
were recorded in testes prior to adding drug treatments. Only 
testes in which cells displayed constant poleward velocity 
during anaphase in Insect Ringer’s were used for drug 
treatments. 
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Figure 38 – Average speeds for kinetochores with non-constant 
poleward velocity in Insect Ringer’s. Kinetochores sometimes 
slowed during anaphase in Insect Ringer’s (n=13/72) (green). 
These kinetochores moved with an average initial speed of 
0.53±0.2µm/min and then slowed to approximately 33% of their 
initial anaphase speed. Most of these kinetochores then 
increased in speed to approximately 88% of their initial 
anaphase speed (n=11/13). Kinetochores sometimes stopped during 
anaphase in Insect Ringer’s (n=12/72) (blue). These kinetochores 
moved with an average initial speed of 0.37±0.2µm/min before 
stopping. After variable amounts of time, these kinetochores 
resumed poleward movement with an average speed of approximately 
109% of their initial anaphase speed. Times indicate minutes 
after anaphase onset. Asterisks indicate significant differences 
in speed (*, p<0.05; **, p<0.05; ***, p<0.05; ****, p<0.05). 
Error bars represent SD. [n=number of kinetochores].     
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Figure 39 – Illustrating non-constant poleward velocity during 
anaphase in Insect Ringer’s. The kinetochores move toward 
opposite spindle poles with an initial separation speed of 
0.6µm/min. Approximately 2.5 minutes after anaphase onset, the 
kinetochores stop moving poleward (grey arrow). Approximately 
6.5 minutes later, the kinetochores resumed poleward movement 
(yellow arrow) with a separation speed of 0.5µm/min. Chromosome 
arms stretched between these separating half-bivalents and then 
retracted within one minute of resumed poleward movement.   
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Table 3 – Average speeds during anaphase in Insect Ringer’s for 
kinetochores with constant and non-constant poleward velocity. 
Times indicate minutes after anaphase onset. [n=number of 
kinetochores].   
Treatment 
Chromosome 
movement 
Number of 
kt. 
 
Speed (µm/min) 
Initial 
anaphase 
speed 
(µm/min) 
Reduced 
speed  
Increased/ 
resumed 
speed 
Insect 
Ringer’s 
Constant 
47  0.50±0.22   
 Time (min)    
Non-
constant: 
slowed 
13  0.53±0.18 0.18±0.096 
0.47±0.16 
[n=11/13] 
 Time (min)  5.68±1.87 12.78±3.22 
Non-
constant: 
stopped 
12  0.37±0.16 Stopped 0.40±0.13 
 Time (min)  6.72±2.94 13.39±5.51 
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Within the testis in which cells displayed non-constant 
poleward velocity during anaphase, chromosome arms were often 
seen stretching between pairs of separating half-bivalents. Each 
half-bivalent has four chromosome arms, that typically trail 
behind the kinetochore as it moves poleward. Of the trailing 
chromosome arms, one arm, from either one or both of the half-
bivalents within a pair, often stretched between the half-
bivalents as they moved toward opposite spindle poles. Most of 
these chromosome arms then retracted toward the kinetochore. 
Table 4 summarizes the occurrence of chromosome arm extension 
and retraction during anaphase chromosome movement in Insect 
Ringer’s. A cell in which a chromosome arm can be seen 
stretching and retracting has also been included (Figure 40). In 
general, between pairs of separating half-bivalents in which one 
of both of the chromosomes moved with non-constant poleward 
velocity, at least one of the half-bivalents displayed 
chromosome arm extension (n=18/25) and retraction (n=13/25). 
Chromosome arms typically retracted within 3 minutes of resumed 
poleward movement (Table 5) and most kinetochores resumed 
movement within the same minute that chromosome arms retracted 
(n=8/12).   
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Figure 40 – Chromosome arm extension and retraction during non-
constant anpahase movement in Insect Ringer’s. Chromosome arms 
sometimes appeared to stretch between separating half-bivalents 
and then retract. In this cell, a chromosome arm (white bracket) 
of the top right half-bivalent can be seen stretching (blue 
bracket) and then retracting (orange bracket). This half-
bivalent slowed down and then increased in speed during anaphase 
in IR. The chromosome arm retracted within the same minute that 
the half-bivalent increased in speed. The yellow asterisk 
represents the kinetochore and the red arrow points to a 
chromosome arm that moves ahead of the kinetochore during 
anaphase.  
 
 
 
 
 
106 
 
Table 4 – Summary of chromosome arm extensions and retractions 
for autosomal half-bivalents during anaphase in Insect Ringer’s. 
A chromosome arm from one or both of the half-bivalents within a 
pair were seen stretching toward the opposite half-bivalent and 
then retracting during anaphase chromosome movement. Sometimes, 
chromosome arms could not be clearly seen stretching and 
retracting and have been included as “cannot conclude”.  
Anaphase 
movement  
Total 
number 
of kt. 
Number of kinetochores 
No arm 
extension 
or 
retraction  
Arm 
extension 
& 
retraction  
Arm 
extension 
(retraction 
not 
visible)  
Partner 
half-
bivalent’s  
arm 
extension & 
retraction 
Cannot 
conclude  
Constant 47 45 2 
 
 
 
Non-constant: 
slows or stops 
and then 
resumes 
23 3 9 5 3 3 
Non-constant: 
slows 
2 
 
1 
 
 1 
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Table 5 – Absolute difference in time between chromosome arm 
retraction and resumed poleward movement during anaphase in 
Insect Ringer’s.   
 
Absolute difference in time between arm retraction and resumed 
movement (minutes) [n=12] 
0 min. 0.5 min. 1 min. 1.5 min. 2 min. 3 min. 
Number of 
kinetochores 
(with resumed 
movement) 
5 1 2 2 1 1 
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Discussion 
The purpose of my thesis was to investigate possible roles for 
tropomyosin during anaphase chromosome movement. This was 
accomplished by treating cells with inhibitory drugs against 
tropomyosin during anaphase and by localizing tropomyosin in the 
spindle. Overall, my results suggest that tropomyosin is present 
in the spindle and there is indication from inhibitors that 
tropomyosin might be involved. This was one of the first 
attempts to characterize spindle tropomyosin and test whether it 
plays a role during anaphase chromosome movement. With the 
exception of a recent study conducted in Drosophila S2 cells 
(Goins and Mullens 2015), tropomyosin has not been localized in 
the spindle or tested for functional roles during mitosis or 
meiosis. 
Anaphase chromosome movement following drug treatments 
Cells were treated with two different inhibitory drugs against 
tropomyosin during anaphase. These drugs, PD and TR100, inhibit 
tropomyosin through different mechanisms; however, they both 
ultimately result in actin filament disorganization and degraded 
actin filament function (Houle et al. 2003, Houle et al. 2007, 
Stehn et al. 2013). Previous experiments involving PD and TR100 
showed their inhibitory effects after long incubation periods. 
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For example, cells with altered actin filament dynamics were 
incubated with PD for 1 hour (Houle et al. 2003, Houle et al. 
2007) or were treated with TR100 for typically 24-hours, or at 
least 1 hour (Stehn et al. 2013). In my experiments, I tested 
the immediate (within several minutes) effects of these drugs on 
chromosome movement during anaphase.     
PD treatment 
PD inhibits tropomyosin phosphorylation and alters the actin 
microfilament system (Houle et al. 2003, Houle et al. 2007). 
Cells in anaphase were treated with PD at both low [50 µM] and 
high [100 µM] concentrations. PD altered movement in over 70% of 
the chromosomes studied. Immediately following PD treatment, 
affected kinetochores either slowed, slowed and then stopped, or 
stopped moving poleward. Usually, partner half-bivalents reacted 
the same (n=50/63 kinetochores). However, between cells and 
within the same cell, bivalent pairs reacted differently. The 
same pattern has been observed in crane-fly primary 
spermatocytes following treatment with inhibitory drugs against 
actin and myosin (Forer and Pickett-Heaps 1998, Silverman-
Gavrila and Forer 2001, Sheykhani et al. 2013), in that, while 
partner half-bivalents typically react the same to anti-actin 
and anti-myosin drugs, different bivalent pairs may react 
differently. This variability may be accounted for by functional 
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differences amongst individual kinetochore fibres (reviewed in 
Xie and Forer 2008). For example, kinetochore microtubules 
within the same spindle may originate from either the 
kinetochore or the centrosome and individual kinetochore fibres 
display different rates of tubulin flux. Thus, individual 
kinetochore fibres within the same spindle display different 
dynamics and possibly different force generating mechanisms. 
These data suggest that different bivalent pairs may use 
different force generating mechanisms to move chromosomes and 
that different combinations of these mechanisms can be used 
within the same spindle (Forer and Pickett-Heaps 1998, Xie and 
Forer 2008). This explains why different bivalent pairs reacted 
differently to PD.  
Furthermore, stopped kinetochores often resumed movement 
while still in PD (n=20/28). Kinetochores also resume movement 
after stopping in the presence of anti-actin and anti-myosin 
drugs (Forer and Pickett-Heaps 1998, Silverman-Gavrila and Forer 
2001, Fabian and Forer 2005, Sheykhani et al. 2013). It appears 
that chromosomes are able to resume movement because crane-fly 
primary spermatocytes have redundant mechanisms for chromosome 
movement and, when one mechanism is inhibited, chromosomes can 
switch to another. This was tested by Fabian and Forer (2005) 
who showed that chromosomes normally use actin-based mechanisms 
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for anaphase movement but when actin is removed in early 
prometaphase, producing actin-free spindles, anaphase chromosome 
movement proceeds normally. This suggests while chromosomes 
normally may use actin-based mechanisms for anaphase movement, 
they can use alternative mechanisms when actin is not present or 
inhibited. Redundant mechanisms for chromosome movement are 
likely, considering the fundamental importance of chromosome 
motility during cell division, in which faithful chromosome 
segregation is necessary for cell survival. 
Since PD inhibits tropomyosin phosphorylation (Houle et al. 
2003, Houle et al. 2007) and it has been shown here to alter 
chromosome movement during anaphase, this suggests that 
tropomyosin phosphorylation is involved in anaphase chromosome 
movement. Tropomyosin phosphorylation seems to be involved in 
altering the actin-tropomyosin complex, which may have 
implications during anaphase chromosome movement. Specifically, 
tropomyosin phosphorylation stiffens the regions of head-to-tail 
overlap of tropomyosin molecules (Lehman et al. 2015). Rather 
than altering the binding capacity of tropomyosin for F-actin, 
tropomyosin phosphorylation therefore alters the head-to-tail 
binding of contiguous tropomyosin molecules along actin 
filaments. Furthermore, actin-activated myosin-ATPase activity 
is significantly higher in the presence of phosphorylated 
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tropomyosin compared to non-phosphorylated tropomyosin (Heeley 
et al. 1989). This may explain why chromosome movement was 
altered following PD treatment. If PD inhibited tropomyosin 
phosphorylation, then chromosome movement may have been affected 
because of reduced levels of actin-activated myosin-ATPase 
activity along kinetochore fibres. It is therefore worthwhile to 
investigate whether altered anaphase chromosome movement, 
following PD treatment, is due to inhibiting tropomyosin 
phosphorylation. This can be determined by measuring the levels 
of tropomyosin phosphorylation with antibodies specific to 
phosphorylated and non-phosphorylated forms of tropomyosin. 
Similar experiments have been conducted in crane-fly primary 
spermatocytes in which myosin phosphorylation levels along 
kinetochore fibres were reduced by ML-7 and Y 27632 (Sheykhani 
et al. 2013).  
TR100 treatment 
TR100 is a specific inhibitor against tropomyosin isoforms 
containing the 9d exon sequence expressed at the protein level 
(Stehn et al. 2013). It negates tropomyosin from conferring 
actin filament stability and disrupts the actin microfilament 
system by binding directly to tropomyosin. Cells in anaphase 
were treated with various concentrations of TR100, ranging from 
25 µM to 100 µM. When added during anaphase, approximately 66% 
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of the chromosomes studied showed no effect following TR100 
treatment. However, approximately 33% of chromosomes slowed, 
stopped or stopped after a few minutes. This data will be 
discussed in the following section with respect to and in 
consideration of other cytoskeletal effects following TR100 
treatment. 
 Cells that were treated with TR100 showed additional 
cytoskeletal effects, indicating that this drug alters the actin 
microfilament system of crane-fly primary spermatocytes. 
Firstly, some cells exhibited membrane blebbing following TR100 
treatment. Membrane blebbing is typically associated with a loss 
of microfilament integrity and apoptosis (Coleman et al. 2001). 
Membrane blebbing has also been observed following PD treatment 
(Houle et al. 2003, Houle et al. 2007) although this was not 
observed here. Membrane blebbing suggests that TR100 may affect 
the actin microfilament system in crane-fly primary 
spermatocytes by inhibiting tropomyosin.  
Secondly, cleavage furrows were inhibited by TR100. In 
control conditions, cleavage furrows typically appeared after 34 
minutes following anaphase onset. However, in 80% of cells 
treated with TR100, cleavage furrows did not appear. In one 
cell, a cleavage furrow appeared, ingressed for a few minutes 
but then quickly regressed and did not cleave. This suggests 
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that the contractile mechanism involved in cleavage furrow 
ingression is inhibited by TR100.  
Cleavage furrows ingress during cytokinesis, through an 
actomyosin based contractile mechanism (Schroeder 1973, Fujiwara 
and Pollard 1976, Fujiwara et al. 1978, Sanger and Sanger 1980, 
Komatsu et al. 2000, Vavylonis et al. 2008). The data presented 
here suggests that cleavage furrow ingression may depend on 
tropomyosin and that TR100 inhibits tropomyosin from conferring 
actin filament function in the contractile ring. Similar results 
were obtained in crane-fly primary spermatocytes treated with 
anti-myosin drugs (Silverman-Gavrila and Forer 2001). Briefly, 
when added after cleavage furrow initiation, BDM inhibited 
further ingression. After wash out, the cleavage furrow began to 
ingress again but then quickly regressed. In general, BDM and 
ML-7, which reduce myosin phosphorylation, prevent cleavage 
furrow ingression (Silverman-Gavrila and Forer 2001).  
Lastly, bunches of actin filaments were often seen 
protruding at the spindle poles prior to anaphase onset and are 
referred to as “actin fingers” (Xie and Forer 2008). As early as 
2-3 minutes following TR100 treatment, these actin fingers began 
to change shape. They became progressively thicker and shorter, 
with gross changes in the actin fingers appearing approximately 
20 minutes after treatment with TR100. Eventually, the actin 
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fingers disappeared from most of the cells in which fingers were 
present prior to TR100 treatment. Overall, these data suggest 
that TR100 affects the actin microfilament system in crane-fly 
primary spermatocytes, presumably by inhibiting tropomyosin and 
preventing tropomyosin from conferring actin filament stability. 
Taken together, the data presented here suggest that TR100 
affects the actin microfilament system of crane-fly primary 
spermatocytes and that anaphase chromosome movement may be 
largely unaffected because of timing constraints. In general, 
not all chromosomes studied during anaphase are affected by 
inhibitory drugs, such as those against actin and myosin, 
possibly because of redundant mechanisms for chromosome movement 
(Forer and Pickett-Heaps 1998, Silverman-Gavrila and Forer 2001, 
Fabian and Forer 2005, Xie and Forer 2008, Sheykhani et al. 
2013). However, PD affects chromosome movement in over 70% of 
the chromosomes studied during anaphase. This suggests that 
tropomyosin is involved in anaphase chromosome movement.  
In consideration that TR100 affected other cytoskeletal 
functions, especially those involving actin filaments, it seems 
likely that chromosome movement was unaffected in 66% of the 
chromosomes studied during anaphase because of time constraints.  
Cells were treated with TR100 after anaphase onset, as autosomal 
half-bivalents moved toward the spindle poles. By the time that 
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TR100 permeated the cell and inhibited tropomyosin, chromosomes 
may have reached or neared the spindle poles. Previous studies 
involving TR100 have shown that it affects actin filament 
dynamics after incubation periods of several hours, ranging from 
1-24 hours (Stehn et al. 2013, Bonello et al. 2016). In my 
experiments, the immediate effects (within several minutes) of 
TR100 were tested. Furthermore, TR100 binds to free tropomyosin 
molecules that are not already bound actin filaments (Bonello et 
al. 2016). Therefore, tropomyosin molecules would have to be 
incorporated into the kinetochore fibres following TR100 
treatment, in order to affect actin filaments along the 
kinetochore fibres. Together, this suggests that TR100 may not 
have robust effects on chromosome movement when added during 
anaphase, due to the limited time during which TR100 can affect 
tropomyosin along kinetochore fibres. In order to test this, 
TR100 can be applied in late prometaphase-I to metaphase-I. The 
data presented here, specifically changes in the actin fingers, 
suggest that TR100 may take several minutes to affect the actin 
filament integrity. Therefore, if TR100 is added before anaphase 
onset, there may be enough time for TR100 to bind to tropomyosin 
molecules before they are incorporated into kinetochore fibres. 
These chromosomes may display abnormal anaphase movement if they 
use a mechanism involving tropomyosin. 
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Tropomyosin localization in the spindle  
Tropomyosin was localized in the spindles of crane-fly primary 
spermatocytes using two different antibodies against 
tropomyosin. Tropomyosin isoforms display varying degrees of 
reactivity toward different antibodies but, generally, 
antibodies can be classified as binding to low molecular weight 
(LMW) or high molecular weight (HMW) isoforms (Schevzov et al. 
2005, Schevzov et al. 2011). TM311 binds to the 1a exon sequence 
of HMW tropomyosin isoforms and TM5NM1/2 binds to the 9d exon 
sequence of HMW and LMW tropomyosin isoforms (Schevzov et al. 
2005, Schevzov et al. 2011).  
 From prometaphase-I to anaphase-I, tropomyosin localized at 
the spindle poles and along kinetochore fibres, as observed with 
both TM311 and TM5NM1/2. Tropomyosin was anticipated to 
colocalize with spindle actin. Although it might be possible to 
test this, I could not do so because of technical difficulties 
(see Materials and Methods). Nonetheless, tropomyosin localized 
in places where actin would be expected. For example, 
tropomyosin localized along kinetochore fibres, where actin has 
been shown to localize (e.g. Xie and Forer 2008). In addition, 
tropomyosin was observed at the spindle poles. During cell 
division, the centrosome replicates and one centrosome moves to 
each spindle pole (Wade 2009). The centrosome is a microtubule 
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organizing center; however, it also functions as an actin-
filament organizing center (Farina et al. 2016). Briefly, 
isolated centrosomes, are able to polymerize filaments from 
actin monomers, similarly to how they polymerize microtubules 
from tubulin dimers. Tropomyosin affects actin filament 
polymerization (reviewed in Cooper 2002) so it would be likely 
that tropomyosin localizes to actin-organizing centers, such as 
the centrosomes at the spindle poles. Overall, the data suggests 
that tropomyosin is present in the spindle of crane-fly primary 
spermatocytes, including along kinetochore fibres, where it 
would be involved in anaphase chromosome movement.  
Chromosome movement and tropomyosin function  
Tropomyosin was hypothesized to be involved in chromosome 
movement during anaphase primarily because actin and myosin are 
involved in anaphase chromosome movement and tropomyosin 
mediates actomyosin interactions. A recent study has shown that 
tropomyosin localizes to spindle poles and to the kinetochores 
in the mitotic spindle of Drosophila S2 cells (Goins and Mullens 
2015). When this tropomyosin isoform was mutated, so that it 
could no longer be phosphorylated, anaphase chromosome movement 
was unaffected. These results contradict the data presented 
here, which suggest that inhibiting tropomyosin phosphorylation 
affects anaphase chromosome movement. However, in the Drosophila 
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S2 cells, tropomyosin phosphorylation was inhibited by mutating 
specific amino acid residues that differed from those discussed 
in regard to PD (Houle et al. 2003, Houle et al. 2007). 
Furthermore, tropomyosin phosphorylation levels should be tested 
in order to determine whether anaphase chromosome movement is 
altered when tropomyosin phosphorylation is affected along 
kinetochore fibres. Conversely, when the tropomyosin isoform was 
mutated in putative binding sites for troponin, anaphase 
chromosome movement was altered (Goins and Mullens 2015). 
Although this mutated tropomyosin still localized to the spindle 
poles and to the kinetochores, chromosomes exhibited kinetochore 
fibre attachment defects, unfocused spindle poles, delayed 
anaphase progression and abnormal chromosome segregation, for 
example chromosomes often missegregated. These results suggest 
that tropomyosin may function in the spindle through a troponin-
tropomyosin based mechanism. Potentially, this troponin-
tropomyosin based mechanism may function in the spindle 
similarly to how troponin and tropomyosin function in striated 
muscle.  
Future studies regarding the role of tropomyosin during 
anaphase chromosome movement should investigate tropomyosin 
phosphorylation levels along kinetochore fibres following PD 
treatment as well as treating cells with TR100 during 
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prometaphase-I to metaphase-I. This will test whether 
chromosomes segregate normally when tropomyosin is inhibited 
prior to anaphase onset. Furthermore, it may be worthwhile to 
investigate whether another muscle protein, troponin, is also 
involved in anaphase chromosome movement.  
Chromosome arms and non-constant poleward velocity 
In the testes of some animals, cells display non-constant 
poleward velocity during anaphase chromosome movement that is 
associated with chromosome arm stretching and retracting. These 
half-bivalents slow down or stop during anaphase and then, after 
variable amounts of time, resume poleward movement. Most of 
these half-bivalents have chromosome arms that appear to stretch 
or extend toward the partner half-bivalent and then retract 
toward the kinetochore. Chromosome arm retraction often occurs 
within the same minute that poleward movement resumes or, at 
most, within three minutes of resumed movement. This suggests 
that chromosome arm extension and retraction is associated with 
non-constant poleward velocity during anaphase chromosome 
movement. In particular, there may be a force being exerted 
between chromosome arms of separating half-bivalents that 
opposes poleward acting forces and that results in non-constant 
poleward velocity. A possible explanation for chromosome arm 
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stretching and retracting may be faulty “tethers” attaching 
chromosome arms of separating half-bivalents. 
Elastic tethers extend between chromosome arms of 
separating half-bivalents and exert a backward force that 
opposes pole directed forces (LaFountain et al. 2002, Sheykhani 
et al. 2017, Forer et al. 2017). Normally, tethers do not affect 
constant poleward velocity; however, it may be possible that if 
the tether elasticity is somehow altered, then the chromosomes 
will move with non-constant velocity. This seems plausible 
considering that chromosome arms are often seen stretching and 
retracting in half-bivalents that slow or stop and then resume 
movement. The tether extending between chromosome arms is 
composed of titin, which is a muscle protein associated with 
sarcomere elasticity (see Fabian et al. 2007). Although this 
explanation is very speculative, it may explain why the cells of 
some animal testes have chromosomes that move with non-constant 
poleward velocity. As previously mentioned, in order to account 
for this ‘abnormality’, only testes in which cells displayed 
constant poleward velocity were used for drug treatments. 
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